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ABSTRACT 
The Influence of Central Insulin Signals on Stress Response in Mice 
Chi Nok Chong 
 Stress is an anticipatory or actual disruption of homeostasis which triggers 
physiological responses to prepare for the threat or to reestablish the system’s 
internal equilibrium. Other than physical stress (e.g. blood loss, infection, pain, 
and cold) and psychogenic stress (e.g. novel environment (rodent) and 
immobilization (rodent)), nutrient (metabolic) stress such as high fat diet and 
fasting can also trigger stress responses. Central to the activation and regulation 
of the stress response in mammals is the hypothalamus, where signals from the 
periphery and other regions of the brain are integrated and processed. Insulin 
and leptin are two important hormones that provide information about the energy 
status of the body to the hypothalamus. The hypothalamic insulin- and leptin- 
sensing circuits integrate these signals to coordinate metabolic outcomes such 
as food intake, energy expenditure, fuel partitioning, etc. Given the tight 
correlation between stress axis activity and nutrient status, it raises the possibility 
that hypothalamic insulin- and leptin- sensing circuits may also be involved in 
coordinating responses of the stress axis, particularly during stress pertaining 
changes in energy homeostasis. My thesis research focused on understanding 
the roles and the interactions of hypothalamic insulin and leptin signals in 
regulating and coordinating metabolic and hypothalamic-pituitary-adrenal (HPA) 
axis functions.  
 My first project involved understanding the role of hypothalamic insulin 
signals in hypothalamic Leptin receptor deficient animals (L2.1 KO) in regulating 
energy metabolism (Chapter 2). We observed an increase in body weight and 
adiposity in D2.1 KO mice that lack both hypothalamic insulin receptor (InsR) and 
leptin receptor (LepRb) signals. These changes were accompanied by reduced 
energy expenditure, rather than an increase in food intake. Unexpectedly, there 
was a drastic loss in body temperature in D2.1 KO during fasting that was 
significantly exacerbated by single-housing. These results suggest that 
interactions between hypothalamic insulin and leptin signals are important for 
regulating energy expenditure and body temperature. Furthermore, this study 
also highlights the influence of housing conditions on the evaluation of 
thermogenic defects in mice. 
 My second project involved the study of hypothalamic insulin signals in 
regulating stress-related functions by using the non-obese hypothalamic InsR- 
deficient mice (I2.1 KO)(Chapter 3). We showed that I2.1 KOs have elevated 
baseline hypothalamic Avp synthesis, increased activity of the HPA axis after 
restraint, as well as increased anxiety-like behaviors. This study demonstrated 
that hypothalamic InsR signals suppress the stress response to restraint, 
possibly by influencing AVP release to the median eminence and decreasing 
hypothalamic glucocorticoid receptor (GR) signals, and may also modulate 
anxiety-like behaviors.  
 My current research focuses are: to remove InsR signals by using more 
restrictedly expressed Cre lines in order to identify brain nuclei mediating 
insulin’s effect on stress response and/or anxiety-like behaviors; to identify the 
hypothalamic AVP neuronal population affected by the loss of InsR and potential 
extra-hypothalamic downstream targets of these neurons; to pinpoint the 
hypothalamic nuclei where GR signaling is altered in I2.1 KO. By identifying the 
critical anatomical and functional components mediating insulin’s effects, we 
hope to provide more understanding of the contribution of central insulin 
resistance to the development of HPA axis dsyregulation and anxiety disorders in 
humans. 
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CHAPTER 1: BACKGROUND OVERVIEW 
Hypothalamic Regulation of Physiological Functions  
The hypothalamus is consisted of a highly diverse but specialized 
collection of interconnected neurons that allow the sensing and integration of 
peripheral and central signals to coordinate systemic responses, and maintain 
basic physiological functions and homeostasis. Early lesion studies in rodents 
revealed that the hypothalamus influence a wide ranges of essential body 
functions for survival, including appetite and feeding, stress response, 
maintenance of blood pressure, glucose metabolism, and body temperature 
regulation, etc. In this chapter, we will focus on discussing the role of 
hypothalamic circuits in regulating body temperature and stress response.  
Hypothalamic Neural Circuits in Regulating Brown Adipose Tissue 
Thermogenesis 
 Central neural circuits coordinate thermogenic activities in peripheral organs to 
maintain body temperature in response to external (i.e. increased or decreased 
surrounding temperature) as well as internal stressors (i.e. fever, energy deficit). 
Maintenance of body temperature is important, because critical cellular functions are 
altered by deviations in body temperature. Thermogenesis is one of the major 
mechanisms for regulating and maintaining body temperature. There are two types of 
thermogenesis: non-shivering (adaptive) thermogenesis (mediated by brown adipose 
tissue (BAT) and skeletal muscle) and shivering-thermogenesis (mediated by skeletal 
muscle) (Lowell and Spiegelman 2000; Morrison and Nakamura 2011; Bal et al. 2012). 
Since relatively little is known about the central mechanism for regulating shivering 
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thermogenesis and shivering is usually engaged last for maintaining body temperature 
since the thermal threshold required for activation is lower than both cutaneous 
vasoconstriction and BAT thermogenesis (Morrison and Nakamura 2011), this 
discussion will focus on adaptive thermogenesis.  
 CNS circuits influence BAT thermogenesis by regulating sympathetic nerve 
activity (Morrison and Nakamura 2011). Sympathetic activity stimulates the expression 
of BAT Uncoupling-protein-1, which encodes a protein that generates heat by facilitating 
proton leakage across the electronic transport chain on the mitochondrial membranes 
(Morrison and Nakamura 2011). Temperature sensing occurs at several different levels: 
from cutaneous thermal receptors in the skin that respond to external temperature, to 
warm-sensing neurons in the POA which are activated in response to increased local 
temperature (Morrison and Nakamura 2011). Signals from cutaneous thermal receptors 
are transmitted via neurons in dorsal horn of the spinal cord (Craig 2002) to the lateral 
parabrachial neurons (Hylden et al. 1989; Li et al. 2006), which then projects to the POA 
(Nakamura and Morrison 2008; Morrison and Nakamura 2011)  
 Many hypothalamic nuclei, including include the POA, DMH, and PVH, are 
implicated in regulating BAT thermogenesis (Yoshida et al. 2009; Morrison and 
Nakamura 2011). However, the POA is believed to be the main hypothalamic site 
involved in sensorimotor integration of thermoregulation, since most thermoregulatory 
responses are dependent on the integrity of the POA (Morrison and Nakamura 2011). 
The POA is made up of several distinct populations of neurons that regulate 
thermogenesis separately. Warm-sensing neurons in the medial POA (mPOA) have 
been postulated to provide inhibitory signals to neurons in the DMH and rostral raphe 
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pallidus nucleus (rRPa), which normally act to promote BAT thermogenesis (Morrison 
and Nakamura 2011). The role of neurons in the median preoptic area (MnPOA), 
however, remains controversial. While Morrison et al. proposed that MnPOA activates 
thermogenesis by inhibiting neurons in mPOA that inhibit thermogenesis (Morrison and 
Nakamura 2011); Yoshida et al. suggested that neurons in MnPOA and dorsolateral 
preoptic area (DLPO) form parallel inhibitory pathways that modulate BAT 
thermogenesis (Yoshida et al. 2009). This inconsistency likely arose from the difference 
in injection sites and the proximity between the sites being investigated.  
 Downstream of the POA, thermogenesis-promoting DMH neurons project 
(possibly through caudal periaqueductal grey (cPAG)) to premotor neurons in the rostral 
ventromedial medulla, including the rRPa, which provide critical excitatory drive to 
thermal effectors (Morrison and Nakamura 2011). rRPa neurons provide inputs to 
preganglionic neurons in the IML that directly innervate BAT (Nakamura et al. 2004). It 
has been proposed that GABAergic neurons in the DMH that project to the PVH act to 
suppress BAT thermogenesis; however the exact functional and anatomical 
connections between PVH and rRPa are not known (Madden and Morrison 2009; 
Rezai-Zadeh and Münzberg 2013). The hypothalamus represents an important site for 
the integration of local and peripheral information to coordinate thermoregulatory events 
that maintain or alter body temperature in response to physiological needs. The central 
circuits regulating BAT thermogenesis are illustrated in Figure 1.1.  




Figure 1.1: CNS Circuits Regulating BAT Thermogenesis 
Cutaneous thermal sensory signals are transmitted to DH, which contains second-order 
thermal sensory neurons projecting to the LPB. POA neurons receiving thermosensory 
signals from the LPB send inhibitory outputs to the DMH. PVH also send inhibitory 
signals to the rRPa, which provide excitatory inputs to the IML of the spinal cord. 
Activation of the BAT sympathetic preganglionic neurons in the spinal IML increases 
BAT thermogenesis. (Excitatory projections are shown in green; Inhibitory, red) 
Abbreviations: DH (dorsal horn of the spinal cord); LPB (lateral parabrachial nucleus); 
POA (preoptic area); DMH (dorsomedial nucleus of the hypothalamus); NTS (nucleus of 
the solitary tract); PVH (paraventricular nucleus of the hypothalamus); RVM (rostral 
ventromedial medulla); rRPa (rostral raphe pallidus); IML (intermediolateral cell 
column); BAT (brown adipose tissue)  
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Hypothalamic Leptin and Insulin Signals in Regulating BAT Thermogenesis 
 Body temperature is tightly correlated with energy status, especially during 
energy deficiency, when it is important to reduce thermogenesis to preserve energy 
needed to maintain essential body functions for survival. Decreased serum leptin, 
indicative of insufficient energy stores, is associated with decreased thermogenesis. 
Thus, Lepob/ob and Leprdb/db mice lacking leptin signaling exhibit lower body temperature 
at baseline, and are unable to maintain body temperature when subjected to an acute 
cold challenge (Trayhurn and James 1978; Bates et al. 2004). In addition, Leprdb/db mice 
dramatically reduce body temperature in response to fasting (Kinoshita et al. 2000). 
Leptin’s effect on thermoregulation is believed to be partially mediated by hypothalamic 
neural circuits. In the CNS, Leprb expressing neurons in the POA and DMH/DHA 
(dorsal hypothalamic area) are labeled by pseudorabies virus (transsynaptic viral 
retrograde tracer) injected into the BAT (Rezai-Zadeh and Münzberg 2013), providing 
anatomical evidence to support a role of these neurons in mediating leptin’s 
thermogenic effects. Supporting this idea, leptin injections into the DMH increase BAT 
sympathetic outflow (Enriori et al. 2011).  
 Similar to leptin, serum insulin levels reflect the energy status of an animal 
and have been shown to be involved in body temperature regulation and 
thermogenesis. STZ-treated rats cannot maintain body temperature in response 
to food restriction (Kinoshita et al. 2000). The effect of insulin on BAT 
thermogenesis is known to be partially mediated by hypothalamic insulin sensing 
circuits in the POA. Insulin signals directly inhibit warm-sensing neurons in the 
POA and increase sympathetic tone as well as BAT thermogenesis (Sanchez-
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Alavez et al. 2010). These studies supported the idea that both hypothalamic 
insulin and leptin signals are involved in thermoregulation by influencing BAT 
thermogenesis. 
Regulation of Stress Response (in Mammals) by Hypothalamic Circuits  
 Stress response promotes physiological adaptations that protect and prepare the 
animals for actual or anticipated threats to their well-being, and acts to maintain and 
restore physiological balance of the internal environment following the challenge. A wide 
variety of external and internal stimuli can elicit a stress response, including physical 
(blood pressure, pain, inflammation), psychological (smell, restraint), and nutritional 
(fasting, hypoglycemia) signals. There are two types of stress responses: the endocrine 
response and the autonomic response.  
 The endocrine stress response involves the stimulation of the adrenal gland 
through hormonal factors released from the hypothalamus and the pituitary, ultimately 
leading to an increase in the release of corticosterone (CORT) in rodents or cortisol in 
humans. Activation of the hypothalamic-pituitary-adrenal (HPA) axis elicits a slower-
acting response than the autonomic stress response, as CORT levels take at least ten 
minutes to peak after exposure to a stressor (Ulrich-Lai and Herman 2009). The stress 
response initiated by the HPA axis involves the activation of neurons in the PVH, mainly 
corticotrophin-releasing hormone (CRH) and arginine vasopressin (AVP) neurons, 
which secrete the respective peptide hormones into the hypophyseal-portal circulation 
in the median eminence. These hormones in turn stimulate corticotrophs in the anterior 
pituitary to release adrenocorticotropic hormone (ACTH), a 39-amino acid peptide 
derived from proopiomelanocortin (POMC), into the peripheral circulation. ACTH then 
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acts on the inner adrenal cortex (zona fasciculate) to increase synthesis and release of 
glucocorticoids (GC). The released GCs act both centrally and in the pituitary to provide 






Figure 1.2: Endocrine Stress Response (Hypothalamic-Pituitary-Adrenal Axis). 
PVH integrates signals coming from the brainstem, BNST (which relays signals from the 
limbic forebrain), POA, and DMH to generate the appropriate stress response. 
Parvocellular PVH neurons release AVP and CRH into the ME and the hypophyseal-
portal circulation. CRH and AVP signaling in the anterior pituitary stimulate the 
synthesis of ACTH and its release into the circulation. ACTH acts on cells in the adrenal 
cortex to stimulate GC production. Negative feedback actions of GCs are mediated 
through glucocorticoid receptors in the limbic forebrain, PVH and the pituitary.  
(Hormonal signals are indicated in red) Abbreviations: PVH (paraventricular nucleus of 
the hypothalamus); BNST (bed nucleus of the stria terminalis); POA (preoptic area); 
DMH (dorsomedial nucleus of the hypothalamus); AVP (arginine vasopressin); CRH 
(corticotropin-releasing hormone); ME (median eminence); ACTH (adrenocorticotropic 
hormone); CORT (corticosterone)  
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 The autonomic stress response is critical for responses to acute physiological 
and homeostatic stressors. Major homeostatic imbalances, such as blood loss and pain, 
are sensed by peripheral organs, which send afferent signals to the brainstem. The 
nucleus of the solitary tract (NTS) in the brainstem relays this information to the rostral 
ventrolateral medulla, locus coeruleus, and paraventricular nucleus of the hypothalamus 
(PVH). The response to the stressor is then transmitted to the intermediolateral cell 
column of the spinal cord, which relays the information to peripheral organs. Direct 
innervation of the adrenal gland by sympathetic nerves that project from the spinal cord, 
allows for rapid transmission of stress-related stimuli through the release of 
catecholamines (ephinephrine/norephineprhine) from chromaffin cells in the adrenal 
medulla (Figure 1.3). The effects of catecholamines on target organs include a wide 
range of physiological adaptations that redirect the body’s energy and resources to deal 
with the threat, such as increasing heart rate and blood pressure.  





Figure 1.3: Autonomic Stress Response. After receiving afferent signals from 
peripheral sensory organs, the brainstem (NTS) relays this information to the PVH 
(which also receives input from DMH), LC and RVM, where pre-autonomic signals are 
believed to be initiated. The IML of the spinal cord relays these signals to the adrenal 
medulla through direct sympathetic innervations. Sympathetic activation of the adrenal 
medulla eventually leads to the release of NE and E. (Autonomic projections are shown 
in light blue) Abbreviations: NTS (nucleus of the solitary tract); PVH (paraventricular 
nucleus of the hypothalamus); DMH (dorsomedial nucleus of the hypothalamus); LC 
(locus coeruleus); RVM (rostral ventromedial medulla); IML (intermediolateral cell 
column); NE (Norepinephrine); E (Epinephrine)  
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 Although the endocrine and the autonomic stress responses involved many 
different brain nuclei, there is a substantial degree of overlap between key components 
of the autonomic and endocrine stress responses in the hypothalamus. For example, 
neurons in the NTS, a critical node in autonomic circuits, can also modulate HPA axis 
activity through the release of neuropeptide Y (NPY), glucagon-like peptide 1, 
somatostatin and enkephalin to the PVH (Ulrich-Lai and Herman 2009). Conversely, 
pre-autonomic oxytocin (OXT) neurons that project from the PVH to the NTS influence 
sympathetic output to the adrenal glands (Buijs et al. 1999). The sympathetic nervous 
system also innervates the adrenal cortex and regulates corticosteroid release (Steckler 
et al. 2005). In the periphery, catecholamines can directly stimulate GC release from 
adrenocortical cells (Ehrhart-Bornstein 1998). 
 Other than central signals, peripheral hormones can also act on PVH neurons to 
influence the activity of the HPA axis. For example, elevated circulating angiotensin II 
stimulates HPA axis activity through projections from the subfornical organ to the PVH 
(Tanimura et al. 1998). In addition, sex steroids such as estrogen exerts a strong 
stimulatory influence on HPA axis responsiveness (Kudielka and Kirschbaum 2005) and 
estrogen receptor antagonist microinjected into the PVH inhibited CORT response to 
stress (Isgor et al. 2003). Since estrogen levels in females fluctuate dramatically during 
the estrus cycle, most studies on the stress axis and its components minimize the 
confounding influence of estrogen on the outcome of the experiments by analyzing 
males. Thus, the PVH represents an important site where information regarding both 
physiological and psychological stress is received and integrated in order to generate 
coordinated autonomic and endocrine responses.  
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Excitatory and Inhibitory Inputs to the PVH 
 Although stress stimuli activate various intra- and extra- hypothalamic regions in 
the brain, including the prefrontal cortex, amygdala, hippocampus, nucleus accumbens 
and hypothalamus, signals from these regions are processed and relayed to the PVH, 
where key regulators of the endocrine and autonomic stress response are located 
(Ulrich-Lai and Herman 2009). 
 The PVH integrates both inhibitory and excitatory inputs from various 
hypothalamic and extra-hypothalamic regions to coordinate the autonomic and 
endocrine responses. The dorsomedial hypothalamus (DMH), and medial preoptic area 
(mPOA) provide major hypothalamic inhibitory signals to the PVH. Stimulation of DMH 
neurons produces inhibitory GABAergic post-synaptic potentials in neurons in the PVH 
(Herman et al. 2003), and activation of ventral DMH, in particular, inhibits neuronal 
activity in the PVH (Ulrich-Lai and Herman 2009). Similarly, the mPOA sends 
GABAergic projections to the PVH, and lesions of the mPOA lead to an increase in 
stress-induced ACTH release (Herman et al. 2003). The limbic forebrain regions also 
provide indirect inhibitory inputs to the PVH mostly through GABAergic neurons in the 
bed nucleus of the stria terminalis and the hypothalamus (DMH, mPOA). These relays 
convert the excitatory glutamatergic outflow from the hippocampus and the prelimbic 
cortex into inhibitory signals to the PVN (Ulrich-Lai and Herman 2009). 
 On the other hand, excitatory inputs to the PVH from the hypothalamus, midbrain 
and brainstem act to increase HPA axis activity. Dorsal DMH likely contains neuronal 
populations that activate the endocrine stress response since inhibiting neurons in that 
region reduces ACTH releases and neuronal activation in PVH during psychogenic 
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stress (Cullinan et al. 1996; 2002). Serotonergic projections from the dorsal and the 
median raphe also increase HPA axis activity and stimulate ACTH and CORT secretion. 
The NTS is the major source of norepinephrine (NE) and epinephrine (E) (excitatory) 
inputs to the PVH, which promote CRH and ACTH release. 
Neuronal Subpopulations that Regulate Stress Responses 
 The stress response can be regulated by several stress factors in the central 
nervous system, including CRH, AVP and Urocortins (UCN). In the PVH, two major 
neuronal populations, CRH and AVP neurons are involved in regulating the 
neuroendocrine arm of the stress axis by influencing ACTH release from the anterior 
pituitary. UCN peptides belong to the CRH family and also bind to CRH receptors; 
however, they have a widespread distribution in the CNS and potentially acts on 
multiple CNS sites to regulate stress responses. 
Corticotrophin-releasing Hormone (CRH) 
 CRH neurons are not only found in the PVH, but also in the neocortex, central 
nucleus of amygdala, the bed nucleus of the stria terminalis, hippocampus, raphe 
nuclei, periaqueductal gray, olfactory bulb, several thalamic and brain stem nuclei, as 
well as the cerebellum (Bale and Vale 2004). However, CRH neurons in parvocellular 
PVH are known to be the critical components of the endocrine stress response, as their 
activation during stress stimulates ACTH release from the pituitary. In rats, the majority 
(~80%) of the CRH neurons in the PVH are located in the parvocellular region; while a 
smaller number (~15%) are found in the magnocellular region (where AVP and OXT 
predominate) and co-express Avp (Swanson et al. 1983). The organization of mouse 
PVH neurons is illustrated in Figure 1.4. When CRH neurons are activated, CRH is 
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released from the axonal terminals in the external zone of the median eminence to the 
hypophyseal-portal system, and finally to the pituitary, where it potently stimulates 
ACTH release and Pomc gene transcription (Autelitano et al. 1989) through binding to 
its receptor (CRH receptor 1, CRHR1) on corticotrophs. In the pituitary, Crhr1 mRNA 
levels positively correlate with Pomc expression (Birnberg et al. 1983). During acute 
stress, there is a rapid release of CRH and an increase in Crh primary transcript within 5 
to 30 minutes after stress (Luo et al. 1994), and CRH antagonists or antibodies can 
suppress the majority of ACTH release (Bale and Vale 2004). Not surprisingly, loss of 
CRHR1 function in mice leads to a failure of ACTH and CORT production during the 
diurnal peak (Smith et al. 1998), in response to stress (Bale and Vale 2004) or CRH 
stimulation (Muller et al. 2001); however, baseline ACTH and CORT levels are normal. 
These studies supported the idea that CRH is a critical player in the activation of the 
HPA axis.  





Figure 1.4: Neuroendocrine Organization of the Mouse PVH (Adapted from Biag 
2012) In the rostral PVH (left panel), parvocellular neurons release CRH into the ME, 
and magnocellular AVP and OXT neurons release the respective peptides directly into 
the posterior pituitary. In the caudal PVH (right panel), parvocellular CRH and AVP 
release their peptides into the ME. Peptides released into the ME reach the anterior 
pituitary through the hypophyseal portal circulation and result in the release of ACTH, 
which stimulates cells in the adrenal cortex to release GCs. The autonomic division of 
the PVH sends direct projections to the IML, which innervates the adrenal medulla. 
(Autonomic projections are shown in light blue and hormonal signals in red) 
Abbreviations: PVH (paraventricular nucleus of the hypothalamus); CRH (corticotropin-
releasing hormone); ME (median eminence); AVP (arginine vasopressin); OXT 
(oxytocin); ACTH (adrenocorticotropic hormone); GCs (glucocorticoids); IML 
(intermediolateral cell column); NE (norepinephrine); E (epinephrine); SNS (sympathetic 
nervous system) 
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 There are two CRH receptors: CRHR1 and CRHR2. In the central nervous 
system (CNS), Crhr1 is widely distributed and is found in the hypothalamus, cortex, and 
cerebellum; Crhr2 is expressed in the hypothalamus (PVH), lateral septum, and the 
olfactory bulb. In the periphery, Crhr1 is expressed in the adrenal cortex (Müller 2001). 
Conditional knockouts have been generated by various groups to study the functions of 
CRHR1 in the CNS without disrupting its function in the pituitary or adrenal glands. 
Camk2a-Cre-mediated recombination of a floxed Crhr1 allele, which disrupts CRHR1 
function in many forebrain neurons, did not affect basal HPA activity or response to 
restraint stress; however, both ACTH and CORT levels remained high after stress 
(Müller et al. 2003). These findings are consistent with a role for forebrain CRHR1 in 
providing negative feedback to the HPA axis, but do not support a role in the initiation of 
the stress response. It should be noted that Crhr1 is highly expressed in the DMH and 
arcuate nucleus of the hypothalamus (ARH), and is induced in these regions in 
response to psychogenic stressors that stimulate CRH and AVP neurons in the PVH 
(Aguilera et al. 2004; P de Gortari 2012). However, little is known about the relative 
contribution of CRHR1 signaling in the PVH, DMH and ARH to the phenotype of the 
Camk2a-Cre-mediated knockout.  
 In contrast to CRHR1, stimulating pituitary CRHR2 in vivo and in vitro does not 
elicit the release of ACTH. As is the case for Crhr1 knockouts, mice lacking Crhr2 have 
normal baseline ACTH and CORT (Bale et al. 2000; Kishimoto 2000; Preil et al. 2001). 
Understanding the role of CRHR2 has been complicated by the discrepancies in the 
phenotypes of Crhr2 null mutants in response to acute stress reported by various 
groups. Kishimoto et al. reported that Crhr2 knockout mice have normal stressed levels 
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of ACTH and CORT at 10 minutes (Kishimoto 2000). However, Coste et al. and Bale et 
al. both reported that Crhr2 knockout mice exhibit elevated CORT levels at 10 minutes, 
but not at 2 minutes after the initiation of the restraint test. Discrepancies between these 
findings are likely due to differences in experimental conditions. One of the factors that 
is known to significantly affect HPA axis reactivity is the housing situation of mice prior 
to experiment. Isolation of mice from weaning leads to heightened HPA axis response 
to restraint stress (Williams et al. 2009). The length of the single-housing period of the 
mice was only reported by one of the groups and it is not known whether the other two 
groups subjected their experimental mice to long-term isolation early on in life. If that is 
the case, this could potentially explain the discrepancy in the results of the restraint test 
on Crhr2 knockout mice among the various groups. Despite the inconsistencies in the 
phenotypes reported for Crhr2 null mutants, at least two of the groups have shown 
increased CORT levels during restraint. Interestingly, the Coste group also noticed an 
increase in CORT levels in these mutant 90 minutes after the restraint has stopped 
(Coste et al. 2000). These findings are consistent with the idea that central CRHR2 
signaling provides negative feedback to activated HPA axis. 
Arginine vasopressin (AVP) 
 AVP is primarily produced by the magnocellular neurons in the PVH and 
supraoptic nucleus (SON). These neurons project to the posterior pituitary and release 
the peptide into the circulation where they modulate fluid and electrolyte homeostasis 
(Wotjak et al. 2002). On the other hand, a small population of parvocellular neurons in 
the PVH releases AVP into the median eminence, where it influences anterior pituitary 
function through the hypophyseal-portal system (Antoni 1993; Tanoue et al. 2004). In 
	  	   17 
the pituitary, AVP appears to potentiate the effect of CRH on ACTH release, but does 
not appear to act directly. In response to psychological stress stimuli such as restraint, 
there is an increase in Avp expression in the parvocellular neurons (and not in the 
magnocellular neurons) of the PVH, as well as in AVP protein levels in the median 
eminence (Herman 1995; Ma et al. 1997a). Stress-induced increases in Avp 
transcription have been observed after 1-2 hours, and thus are delayed relative to the 
immediate increase in Crh transcription (which is observed within 5-30 minutes) (Ma et 
al. 1997a). Although AVP does not appear to stimulate Pomc transcription alone or in 
combination with CRH (Gillies et al. 1982; Abou-Samra et al. 1987), it markedly 
potentiates the stimulatory effect of CRH on ACTH release, partially via enhanced 
cAMP production (Gillies et al. 1982; Abou-Samra et al. 1987; Tanoue et al. 2004).  
 There are several AVP receptors: AVPR1A, AVPR1B, and AVPR2. Avpr1b is 
highly expressed on anterior pituitary corticotrophs, while both Avpr1a and Avpr1b are 
expressed in the CNS (AVPR1A: suprachiasmatic nucleus, PVH; AVPR1B: PVH, DMH, 
olfactory bulb, suprachiasmatic nucleus, SON) (Hurbin et al. 1998; Vaccari et al. 1998; 
Guillon et al. 2004). Avpr1b knockout mice are unable to mount a full ACTH response to 
most acute stressors (restraint, forced swim, novel environment), while the CORT 
response is largely intact in most cases, suggesting that there might be compensatory 
changes in the adrenal glands to maintain the stress response (Tanoue et al. 2004; 
Roper et al. 2011). Although AVP is capable of potentiating the stimulatory effect of 
CRH on ACTH releases, unlike CRH, AVP does not appear to be absolutely required for 
normal acute stress response. Other studies also suggested that hypothalamic AVP 
neurons might be involved in long-term regulation of the stress axis, particularly for 
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sustaining responsiveness to chronic stress (Aguilera et al. 2008). 
Urocortin (UCN) 
 Urocortins are CRH-related neuropeptides that can also bind to CRH receptors. 
Three urocortins have been identified so far. While CRH is bound in a highly preferential 
manner by CRHR1, UCN1 binds with high affinity to both CRHR1 and CRHR2, and 
UCN2 and UCN3 bind selectively to CRHR2 (Lewis et al. 2001; Reyes et al. 2001; 
Ryabinin et al. 2012). The three urocortins are distributed differentially throughout the 
CNS. Ucn1 is mainly expressed in the centrally-projecting Edinger-Westphal nucleus 
(Ryabinin et al. 2012). Ucn2 mRNA is mainly found in the PVH magnocellular region, 
SON, and the ARH in the hypothalamus, as well as the locus coeruleus, the trigeminal, 
facial and hypoglossal motor nuclei and the meninges (Reyes et al. 2001). Ucn3 mRNA 
is expressed in the hypothalamus (the median preoptic area, ventral premammillary 
nucleus, and the bed nucleus of stria terminalis), perifornical area, superior olivary 
nucleus, parabrachial nucleus, amygdala, and the brainstem (Lewis et al. 2001). 
Disparities in the distribution of these peptides have been reported in different strains of 
mice (Weitemier et al. 2005; Ryabinin et al. 2012). 
 To study the individual roles of UCN peptides in HPA axis function, various 
groups have generated mice lacking a single urocortin peptide. Multiple Ucn1 null 
mutant models have been reported to exhibit normal baseline and restraint stress-
induced HPA axis activity (Vetter et al. 2002; Wang et al. 2002; Zalutskaya et al. 2007; 
Ryabinin et al. 2012). In mice lacking either Ucn2 or Ucn3, circadian rhythms of ACTH 
and CORT secretion are normal, as are stress-induced HPA axis responses (Chen et 
al. 2006; Deussing et al. 2010; Ryabinin et al. 2012). Consistent with results from the 
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knockout studies, Ucn3 overexpressing mice also show normal baseline as well as 
restraint-induced CORT release (Neufeld-Cohen et al. 2012). Although Ucn1/Ucn2 
double knockout mice exhibit normal initiation of stress-induced response; they show a 
delay in recovery after stress (Neufeld-Cohen et al. 2010a; Ryabinin et al. 2012). 
Furthermore, mice lacking all three UCN peptides have normal baseline CORT levels, 
similar to what was found in Crhr2 knockout mice. Yet, stress-induced CORT levels 
were not reported (Neufeld-Cohen et al. 2010b; Ryabinin et al. 2012).  
 Together, these studies are consistent with the idea that UCNs do not play a 
major role in regulating the baseline tone of the HPA axis or the initiation phase of the 
response to restraint stress. Similar to the Crhr2 knockout mice, Ucn1/Ucn2 double 
knockout mice show diminished ability to negatively regulate an activated HPA axis. 
This is consistent with the idea that the UCN/CRHR2 system plays a role in terminating 
the HPA axis response to stress. It is important to realize that since these knockout 
models involve the removal of gene function from birth, compensatory mechanisms 
could diminish the HPA axis phenotypes. Therefore, spatial- and temporal- specific 
genetic manipulations are needed to further elucidate the role of UCNs in regulating 
different stages (acute initiation/termination, chronic activation) of the HPA axis 
response.  
Negative Feedback of HPA Axis Stress Response  
 The final product of the activated HPA axis, CORT, plays a variety of 
physiological functions in the body. It acts on peripheral tissues to modulate 
inflammatory responses and promotes stored energy mobilization through altering 
glucose and lipid metabolism, as well as potentiating sympathetic outputs (e.g. 
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vasoconstriction to maintain blood pressure) (Seematter et al. 2004). Another important 
function of CORT is to provide negative feedback to the HPA axis, which is largely 
mediated through the effects in the PVH and pituitary (Ulrich-Lai and Herman 2009). 
CORT can act through two types of receptors: mineralocorticoid receptors (MR), also 
known as type 1 glucocorticoid receptors and encoded by the gene Nr3c2; and 
glucocorticoid receptors (GR), also known as type 2 glucocorticoid receptors and 
encoded by the gene Nr3c1. MRs are mainly localized within the septum, hippocampus 
and the amygdala complex (Reul and de Kloet 1986; Rosenfeld et al. 1990; Gass et al. 
2001; Kretz et al. 2001). They have a high affinity for glucocorticoids and are bound 
substantially even at the circadian nadir of corticosteroid secretion (Ulrich-Lai and 
Herman 2009). GRs are expressed in the pituitary and throughout the central nervous 
system, including the hypothalamus, corticolimbic system, brainstem and spinal cord 
(Reul and de Kloet 1985; Plotsky et al. 1993). They have a low affinity for CORT and 
thus are only activated by high CORT levels, such as during an acute stress response.  
Effects of Glucocorticoids in the PVH 
 Exogenous CORT suppresses Crh and Avp transcription in the PVH as well as 
the secretion of CRH, while adrenalectomy increases Crh expression, consistent with a 
role for glucocorticoids in providing negative feedback to the HPA axis (Plotsky et al. 
1993; Makino et al. 1994; Ma et al. 1997b; Kovács et al. 2000). Increased gene dosage 
of Gr leads to lower basal and restraint-induced CRH levels in the median eminence 
and plasma CORT levels (Reichardt et al. 2000). Conversely, Gr null mutants exhibit 
increased CRH and AVP levels in the median eminence (Kretz et al. 1999).  
 CRH neurons in the PVH express Gr (Coveñas et al. 1993) and CORT-mediated 
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suppression of Crh mRNA is specific to the PVH, as it doesn’t affect Crh expression in 
central nucleus of the amygdala or SON (Itoi et al. 2004), raising the possibility that 
negative regulation of HPA axis by GC occurs at the level of CRH neurons in the PVH. 
Consistent with this idea, CORT microinjections into the PVH before restraint stress 
suppress the induction of Crh hnRNA in the PVH and Pomc hnRNA in the pituitary 
(Weiser et al. 2011). A PVH specific Gr knockout model was generated recently to 
examine the role of PVH GR signaling in HPA axis regulation. Mice heterozygous for Gr 
in the PVH (Single-mined homolog 1 (Sim1)-Cre Gr knockouts) have increased CRH 
protein, as well as ACTH and CORT levels (Jeanneteau et al. 2012). Whereas CORT is 
reported to suppress Avp transcription as well, this likely occurs indirectly, as GR 
expression has not been detected on AVP neurons (Berghorn et al. 1995) and GC 
suppression of AVP gene expression in the hypothalamus requires neural synaptic 
transmission (Kuwahara et al. 2003).  
 In addition to providing negative feedback to the HPA axis during acute stress, 
GCs likely perform a similar role during diurnal fluctuations in HPA axis activity. There is 
a circadian rhythmicity in CORT levels as well as Gr expression, as measured by in situ 
hybridization, in the PVH. In rats, Gr expression is the lowest at the end of the light 
cycle and the highest during early light cycle, which is opposite to circulating CORT 
levels (highest during daytime in humans, nighttime in mice or rats) (Dallman 1993; 
Herman et al. 1993). Circadian fluctuations in Gr expression are thought to be caused 
by GC-mediated down-regulation of its own receptor (Dong et al. 1988; Rosewicz et al. 
1988; Burnstein and Cidlowski 1989). This auto-regulation of Gr expression in the PVH 
potentially represents a powerful negative feedback mechanism mediated by GC to 
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reduce GR signaling when its levels are high. 
 Unlike manipulation of Gr, conditional loss function of limbic forebrain Mr does 
not lead to altered basal HPA activity or response to restraint (Berger et al. 2006). 
Transgenic mice with increased Mr in the forebrain also only lead to a mild suppression 
of the acute stress response in female, but not male, mice (Rozeboom et al. 2007). 
These data strongly support the idea that CRH neurons in the PVH are major targets of 
negative feedback through the GR signaling; signaling through forebrain MRs is less 
likely to be important in this respect. 
Effects of Glucocorticoid Signaling in the Pituitary 
 Pituitary Pomc mRNA and plasma ACTH levels positively correlate with 
circulating GC levels (Birnberg et al. 1983; Watts 2005), as ACTH stimulates GC 
release from the adrenal cortex. On the other hand, GCs are capable of inhibiting both 
Pomc transcription and ACTH secretion in the pituitary (Drouin et al. 1987; Antoni 
1996). Under stressed conditions, rats pretreated with GCs before stress show 
decreased capacity of the pituitary to secrete ACTH in response to stress (Plotsky et al. 
1993; Schmidt et al. 2009). Since the administration of exogenous glucocorticoids 
(dexamethasone, DEX) can decrease Crhr1 mRNA expression in anterior pituitary 
(Zhou et al. 1996), the negative feedback of the HPA axis at the level of pituitary could 
be mediated by the decrease in levels of CRHR1, through which CRH acts to induce 
ACTH release. Although Pomc-Cre (pituitary) Gr knockout adult mice have normal 
baseline and evening CORT levels, as well as normal activation of HPA stress 
response, they exhibit a delay in restoring normal baseline level of HPA axis activity 
after stress (Schmidt et al. 2009). These data are consistent with the idea that pituitary 
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GR signaling exerts an overall inhibitory tone on the HPA axis at both the level of the 
hypothalamus (CRH and AVP neurons) and the pituitary (corticotrophs).  
Effects of Leptin on HPA Axis Activity 
 Leptin is an adipocyte-derived hormone in proportion to the amount of adipose 
tissue which acts in many hypothalamic nuclei to mediate its effect on energy 
homeostasis such as food intake, energy expenditure and glucose metabolism (Ring 
and Zeltser 2010). There is compelling evidence to support an additional role of 
hypothalamic leptin circuits in decreasing HPA axis activity. In addition to severe 
obesity, infertility, growth-retardation, defective thermoregulation, mice without leptin 
(Lepob/ob) or leptin receptor (Leprdb/db) exhibit hypercorticosteronemia (Friedman and 
Halaas 1998). Chronic leptin replacement in Lepob/ob mice suppresses the elevated 
CORT levels (Luque et al. 2007). Leptin can also partially suppress fasting-induced 
increase in CRH release, ACTH, as well as CORT levels in mice (Heiman et al. 1997; 
Ziotopoulou et al. 2000). Furthermore, rats pretreated with physiological levels of leptin 
exhibit suppressed ACTH and CORT response to restraint stress (Heiman et al. 1997). 
Consistent with the rodent data, humans that lack leptin also exhibit hyperactivity of the 
HPA axis (Ozata et al. 1999). Interestingly, these patients have normal basal ACTH and 
cortisol levels, but elevated hormonal levels at the diurnal peak. 
 In vitro and in vivo studies are consistent with the idea that leptin’s effects on the 
HPA axis are likely to be centrally-mediated. Leptin can block CRH secretion from 
isolated rat hypothalamus and cannot directly inhibit ACTH secretion from rat primary 
pituitary cells (Heiman et al. 1997). Moreover, disrupting LepRb signaling throughout the 
CNS (Cohen et al. 2001) or in the hypothalamus (Ring and Zeltser 2010) is able to 
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recapitulate elevated CORT levels observed in Leprdb/db mice. Together these data 
support the idea that central leptin signaling plays a crucial role in suppressing the HPA 
axis during both metabolic and psychological stress.  
Effects of Insulin on HPA Axis Activity 
 Central insulin has been shown to regulate food intake (Brown et al. 2006), as 
well as the metabolism of lipids and glucose in the periphery (Leona Plum 2006). 
Several studies are consistent with the idea that insulin and CORT signaling might be 
cross-repressive. Under baseline conditions, insulin is secreted with a diurnal rhythm 
that is opposite to that of CORT (Dallman et al. 1995). Furthermore, elevated 
glucocorticoid levels lead to systemic (liver, muscle, fat)(Meyuhas et al. 1976; Rizza et 
al. 1982; Pagano et al. 1983; Tappy et al. 1994; Lansang and Hustak 2011) and central 
insulin resistance (Piroli et al. 2007; Osmanovic et al. 2010). Diabetic animal models 
(Streptozotocin (STZ)-treated mice) exhibit hyperactivation of HPA axis, as evidenced 
by elevated ACTH and CORT levels, which is fully reversed by treatment with insulin 
(Chan et al. 2003). The insulin sensitizer, Rosiglitazone, can also suppress stress-
induced CORT release (Ryan et al. 2012). Notably, HPA axis dysregulation is often 
observed in humans suffering from diabetes (Reynolds et al. 2010). 
 There is some evidence to support the idea that insulin’s effects on HPA axis 
activity are, in part, mediated by signaling in the hypothalamus. Female mice with 
decreased FOXO1 (Forkhead box protein O1) signaling in the PVH (which has the 
effect of increasing insulin signals) show a strong trend toward decreased hypothalamic 
Avp expression. Dominant negative form of FOXO1 also directly decreases the activity 
of the Avp promoter (Redemann 2010). Together, these observations are consistent 
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with the hypothesis that central insulin signaling suppresses HPA axis activity through 
the regulation of Avp transcription and synthesis. If central insulin signaling normally 
functions to prevent over-activation of the HPA axis, it could provide a mechanistic basis 
for reported associations between diabetes and psychiatric disorders.  
Regulation of HPA Axis by Hypothalamic Neuropeptides (NPY/AgRP/α-MSH) 
NPY 
 In addition to the hormonal factors (CRH and AVP), other neuropeptides in the 
hypothalamus including neuropeptide Y (NPY), agouti-related peptide (AgRP), and 
alpha-melanocyte-stimulating hormone (α-MSH) can also modulate activity of the HPA 
axis. NPY is a 36 amino-acid neuropeptide that is widely expressed throughout the 
CNS, and about 1/3 of the NPY projections in the PVH originate from neurons in the 
ARH that co-express AgRP (Füzesi et al. 2007). The PVH is densely innervated by NPY 
neurons (Allen et al. 1983; Morris et al. 1989) and Npy Y1 receptor is expressed on 
CRH neurons in the PVH (Dimitrov et al. 2007). Not only does the pattern of diurnal 
fluctuations in hypothalamic NPY levels is similar to that reported for plasma CORT 
levels (i.e. peaking at the end of the light period) (Jhanwar-Uniyal et al. 1990), elevated 
Npy expression in the ARH also coincides with increased plasma CORT levels in 
response to both psychological (i.e. restraint) and nutritional (i.e. fasting) stressors 
(White and Kershaw 1990; Makino et al. 2000; Sweerts et al. 2001; Makimura et al. 
2003; Kas et al. 2005; Sato et al. 2005). Direct injection of NPY into the PVH in vivo 
leads to increased plasma ACTH and CORT levels (Wahlestedt et al. 1987; Haas and 
George 1989), and stimulates AVP release from hypothalamic cultures (Korbonits et al. 
1999). Since pre-treatment with third ventricle infusion of NPY Y1 antagonist is able to 
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abolish the stimulating effect of NPY (Dimitrov et al. 2007) on CORT release in vivo, the 
effect of NPY on HPA axis is likely mediated by the NPY Y1 receptors. These studies 
are consistent with the idea that ARH NPY neurons stimulate HPA axis.  
AgRP 
 In the CNS, AgRP co-expresses with Npy in the ARH (Füzesi et al. 2007). AgRP 
stimulates food intake by antagonizing melanocortin receptor 4 (MC4R) and therefore 
blocking the actions of α-MSH (Ollmann et al. 1997). Despite the opposite effect of α-
MSH and AgRP in regulating food intake, intra-PVH injections of either AgRP or POMC 
similarly increases hypothalamic release of CRH and AVP, and stimulates ACTH 
release (Dhillo et al. 2002). However, since the effect of AgRP on the HPA axis is not 
influenced by the co-administration of α-MSH, it has been suggested to involve other 
independent receptors (Shimizu et al. 2008). While AgRP increases HPA axis activity, 
similar to Npy, it’s mRNA expression is not down-regulated, but rather increased by 
GCs (Hagimoto et al. 2013).  
α-MSH 
 Contrary to AgRP, α-MSH is an agonist of the MC3R and MC4R. It is derived 
from the 241-amino acids precursor polypeptide POMC by specific cleaving enzymes 
PC2 (Benjannet et al. 1991). Arcuate POMC neurons project to the MC4R in the PVH, 
where the major components of the HPA axis are located (Cone et al. 2001), and CRH 
neurons in the PVH also express MC4R (Lu et al. 2003). Consistent with the anatomical 
evidence, α-MSH increases AVP and CRH release from the hypothalamus and 
stimulates ACTH and CORT release in rats (Frijtag et al. 1998; Ludwig et al. 1998; 
Dhillo et al. 2002), and the effect on CORT release is blocked by a selective MC4R 
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antagonist (Lu et al. 2003). These studies are consistent with the idea that α-MSH acts 
directly on PVH CRH neurons to activate the HPA axis. Contrary to in the anterior 
pituitary, where GCs suppress POMC expression, Pomc and α-MSH and levels in the 
medial basal hypothalamus are increased by GCs (Wardlaw et al. 1998). Therefore, the 
hypothalamic melanocortin system (α-MSH and AgRP) appears to stimulate the HPA 
axis, but its components are not subjected to the negative regulation of glucocorticoid 
signaling.  
 Major components of the HPA axis such as CRH and AVP are subject to 
negative feedback regulation by GCs, yet GCs appear to stimulate arcuate Npy (White 
et al. 1994; Shimizu et al. 2008) and medial basal AgRP and Pomc (Savontaus et al. 
2002). GC’s effect on Npy and Agrp expression is possibly mediated by a direct 
mechanism, since ARH NPY/AgRP neurons also express Gr (Hisano et al. 1988). While 
these data are consistent with the hypothesis that ARH POMC and NPY/AgRP neurons 
promote stress responses, the role of these neurons in the regulation of the HPA axis 
during fasting (metabolic stress), and restraint (psychological stress) has not been 
examined. If ARH POMC and NPY/AgRP neurons stimulate the HPA axis, they might 
represent an additional source of negative feedback to the system in addition to GCs. 
Both insulin and leptin have been reported to inhibit the activity of NPY/AgRP neurons 
(Niswender et al. 2004), and thus actions of one or both of these signals could 
potentially provide negative feedback to the HPA axis. On the other hand, leptin 
activates while insulin suppresses POMC neuronal activity (Hill et al. 2010), suggesting 
that insulin, but not leptin provides negative regulation to the HPA axis through POMC 
neurons.  
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Effects of Central Leptin and Insulin Signals on Hypothalamic NPY/AgRP/POMC 
Neurons 
 If there is a need for GC-independent negative feedback to inhibit AgRP/NPY 
and POMC neuronal activity during stress, leptin and insulin might represent two 
possible candidates for this function, as they both hyperpolarize ARH NPY neurons 
(Yang et al. 2010) and insulin also inhibits POMC neuronal activity. In terms of the 
regulation of gene expression, both insulin and leptin decrease Npy and AgRP, and 
increase Pomc expression (Porte et al. 2002). It is interesting to note that insulin 
hyperpolarizes POMC neurons (usually associated with reduced peptide releases) but 
increases Pomc mRNA expression. This suggests a complex and yet unknown 
relationship between the regulation of gene expression and the electrophysiological 
effect of insulin in POMC neurons. Since both central insulin and leptin signals are 
important regulators of NPY/AgRP and POMC neuronal functions and activities, these 
neuronal populations may represent a way of integrating metabolic and stress-related 
signals to modulator HPA axis activity.  
HPA Axis Dysregulation in Animal Models of Psychiatric Disorders 
 There are many types of psychiatric disorders, which include mood/affective 
disorders (e.g. anxiety, depression, bipolar disorder) and psychotic disorders (e.g. 
schizophrenia). HPA axis hyperactivity is commonly seen in patients with anxiety 
disorder, bipolar disorder, as well as depression (Keller et al. 2006; Jokinen and 
Nordström 2009; Zelena 2012). Furthermore, decreased HPA axis sensitivity to 
glucocorticoid suppression and increased sensitivity to CRH have been reported in 
patients with major depression and schizophrenia (Heuser et al. 1994; Lammers et al. 
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1995). Recently, an association has been reported between polymorphisms in AVPR1B 
and CRHR1 genes and susceptibility of bipolar disorder patients to exhibit psychotic 
behaviors (Leszczyńska-Rodziewicz et al. 2012). These studies are consistent with the 
idea that there is a relationship between hyper-activation of the HPA axis and 
psychiatric disorders. The effects of genetic manipulations of distinct HPA axis 
components on anxiety-related behavioral phenotypes (as a surrogate for psychiatric 
disorders) in mouse models are summarized below.  
CRH/UCN 
 Overexpression of CRH, the major PVH component of the HPA axis, leads to 
increased anxious behavior in mice (Keller et al. 2006; Dedic et al. 2012), while Crhr1 
null mice have reduced anxiety (Smith et al. 1998; Timpl et al. 1998). Forebrain specific 
Crhr1 knockouts also exhibit a reduction in anxiety, suggesting that CRHR1 signaling in 
the forebrain increases anxiety-related behaviors. In contrast, CRHR1 signaling in 
midbrain dopaminergic neurons seems to be involved in suppressing pathways that 
increase anxiety as removing Crhr1 from these neurons leads to increase anxiety 
(Müller et al. 2003; Refojo et al. 2011). Loss of the other CRH receptor, Crhr2 has been 
reported to increase anxiety in some strains (Kishimoto 2000), but not others (Vetter et 
al. 2002; Wang et al. 2002; Ryabinin et al. 2012). Similar to some of the Crhr2 knockout 
models, mice that lack all three ligands of CRHR2: UCN1, UCN2 and UCN3, show an 
increase in anxiety-like phenotypes (Neufeld-Cohen et al. 2010b). Although there have 
been some inconsistencies in findings from the various knockout models, most studies 
support a role for the UCN/CRHR2 system in suppressing anxiety-related behaviors 
(Chen et al. 2006; Deussing et al. 2010; Neufeld-Cohen et al. 2010b; Ryabinin et al. 
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2012). While signaling in the CRHR1 system can be anxiogenic (forebrain) or anxiolytic 
(midbrain), the CRHR2 system consistently seems to exert an anxiolytic effect. 
Nevertheless, due to the widespread distribution of the ligands (CRH, UCN1-3) and the 
receptors (CRHR1, CRHR2), conditional knockout models will be needed to parse out 
the roles of the CRH/CRHR1 and the UCN/CRHR2 systems in specific brain regions.  
AVP 
 The other important component of the HPA axis, AVP, has also been implicated 
in the development of anxiety- and depressive-like symptoms in humans (Zelena 2012). 
Rats bred for high anxiety levels show an increase in Avp expression in the PVH 
(Wigger et al. 2004). Injection of AVP also leads to increase in anxiety in rats 
(Appenrodt et al. 1998). Consistently, Avpr1a knockout mice show a reduction in 
anxiety-like behaviors (Bielsky et al. 2004). Therefore, central AVP system is also likely 
to be involved activating pathways that increase anxiety-like behaviors in rodents.  
NPY 
 In addition to CRH/UCN and AVP, the NPY system serves as another example of 
the intricate relationship between the HPA axis and behavioral responses. In addition to 
the previously discussed role of NPY in the HPA axis, central injections of NPY produce 
anxiolytic effects on animal models of anxiety. Similarly, intracerebroventricular 
injections of an NPY Y1 receptor agonist suppresses anxiety-like phenotypes in animal 
models (Britton et al. 1997). This effect has been shown to be partially mediated 
through NPY Y1 receptors in the amygdala where CRH elicits an opposite, anxiogenic 
effect (Thorsell 2010). Though often neglected in discussions of HPA axis regulation, 
NPY Y1 receptor signaling in the amygdala is likely a modulator of anxiety responses 
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during stressful events.  
Glucocorticoid Receptor 
 Mice with conditional loss of glucocorticoid receptor function in the forebrain 
(Alpha Calmodulin-dependent Protein Kinase II (Camk2a)-Cre) or the whole-brain 
(Nestin-Cre) exhibit reduced anxiety-related behaviors (Gass et al. 2001; Boyle et al. 
2005). It is important to note that the whole-brain Gr knockouts exhibit reduced anxiety 
in the face of elevated levels of CRH in the PVH (Tronche et al. 1999). The increase in 
CRH is consistent with the proposed role of GR in providing negative feedback to the 
HPA axis. As PVH neurons project to midbrain centers rich in dopaminergic neurons 
(Geerling et al. 2010) where CRHR1 signaling is reported to be anxiolytic (Refojo et al. 
2011), it is possible that increased CRH signaling to the midbrain contributes to the 
reduction in anxiety in these mice.  
 In conclusion, there are compelling data to support a role for CRH/CRHR1, 
UCN/CRHR2, AVP/AVPR1A, and the GR systems in positively and negatively 
regulating anxiety-related behavioral phenotypes. Whereas AVP, GR and forebrain 
CRHR1 systems are generally anxiogenic, UCN/CRHR2 and midbrain dopaminergic 
CRHR1 systems appear to be anxiolytic. In addition to direct effects of stress hormones, 
interactions with other neuropeptide systems (e.g. NPY) appear to modulate both stress 
response and anxiety. 
Insulin and Psychiatric Disorders 
 Diabetes has been associated with an increased likelihood of developing mental 
disorders, including anxiety, depression, and schizophrenia (Kruse et al. 2003; Kohen 
2004; Lin et al. 2008). At the same time, it has been reported that schizophrenia is often 
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accompanied by metabolic dysregulation, including insulin resistance, impaired glucose 
tolerance and type 2 diabetes mellitus (Bushe and Holt 2004; Harris et al. 2012). 
Furthermore, in a recent publication, by using a computational approach (NETBAG+) to 
analyze schizophrenia-associated genetic variations, insulin signaling has been 
identified as one of the genetic networks that maybe functionally related to the etiology 
of schizophrenia (Gilman et al. 2012). The idea that deficits in central insulin signaling 
contribute to the pathology of mental disorders is also supported by studies using 
mouse models. Treatment with the neuronal insulin sensitizer, dicholine succinate 
(increase autophosphorylation of insulin receptors in neurons), reduces the anxiety 
scores of mice in various stress paradigms (Cline et al. 2012). Conversely, mice with 
deficits in neuronal Akt signaling, a downstream target of insulin signaling, also exhibit 
behavior associated with schizophrenia (Siuta et al. 2010). 
 Manipulations of the CRH, AVP, UCN or GR systems often lead to alterations in 
both HPA axis and anxiety levels in mice. These effects may be mediated via influences 
directly on the HPA axis or via limbic structures. Together with the observation that 
FOXO1 can directly regulate AVP expression (Redemann 2010), it raises the possibility 
that central, possibly hypothalamic, insulin resistance (la Monte et al. 2009; Zhao and 
Townsend 2009) occurring during diabetes could lead to dysregulation of HPA axis 
or/and increased anxiety through altered hypothalamic AVP system. 
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CHAPTER 2: “Hypothalamic Leptin- and Insulin-sensing Circuits 
Coordinate to Regulate Core Body Temperature.” 
Introduction 
 Central injections of both leptin or insulin have been reported to increase 
energy expenditure and reduce food intake (Baskin et al. 1999; Kulkarni et al. 
1999; Xu et al. 2008). Both hormones also activate similar signaling cascades 
including the phosphoinositide 3-kinase (PI3K) and mitogen-activated protein 
kinase (MAPK) pathways to regulate energy intake (Schwartz and Zeltser 2013). 
While insulin does not stimulate signal transducer and activator of transcription 3 
(STAT3) phosphorylation directly, it can potentiate leptin-induced STAT3 
signaling (Carvalheira et al. 2001). Given the similar metabolic functions and 
receptor distribution of leptin and insulin in the hypothalamus (Schwartz and 
Zeltser 2013), it is therefore possible that interactions between hypothalamic 
insulin- and leptin-sensing circuits may provide a way to integrate information 
within the homeostatic circuits to maintain energy balance. Our lab has 
previously reported mice that lack hypothalamic leptin receptor (LepRb) signals 
(L2.1 KO) exhibited a continuous increase in adiposity until 8 weeks of age, when 
stabilization of adiposity was observed. The increasing adiposity was 
accompanied by a progressive development of hyperinsulinemia, raising the 
possibility that increased central insulin signaling could act to limit further 
increase in the adiposity (Ring and Zeltser 2010). Since many of insulin’s effects 
on energy metabolism are known to be mediated by hypothalamic circuits, we 
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embarked on a project that studied the contribution of hypothalamic insulin 
receptor (InsR) signals in L2.1 KO to regulate energy homeostasis. 
This chapter consists of a manuscript in preparation that describes the 
characterization of the metabolic phenotypes in Nkx2.1-Cre mediated conditional 
knockout animals that lack the majority of hypothalamic insulin (I2.1 KO), leptin 
(L2.1 KO) or both receptors (D2.1 KO). The goal of the study is to provide some 
understanding into the nature of the interactions between hypothalamic InsR and 
LepRb signals in regulating body weight and energy metabolism.  
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Hypothalamic Leptin- and Insulin-sensing Circuits Coordinate to Regulate 
Core Body Temperature. 
Manuscript in preparation 
CN Angie Chong, Richard A Greendyk, Lori M Zeltser 
Abstract 
 Central injections of insulin and leptin activate similar intracellular 
pathways and evoke similar sets of physiological responses, raising the 
possibility that interactions between circuits sensing these signals help to 
coordinate physiological processes that maintain energy balance. Opportunities 
for cross-talk are particularly abundant in the hypothalamus, where networks of 
insulin- and leptin-sensing neurons are highly enriched and interconnected. To 
examine whether leptin and insulin signaling networks in the hypothalamus 
interact to regulate energy homeostasis, we used an Nkx2.1-Cre driver to 
generate conditional knockouts of leptin receptor (L2.1 KO), insulin receptor (I2.1 
KO), and double knockouts of both receptors (D2.1 KO). Consistent with previous 
reports, L2.1 KO males were hyperphagic and severely obese, while I2.1 KO males 
were similar to controls. Disruption of both signaling networks resulted in D2.1 KO 
(males) with higher body weight and adiposity than L2.1 KOs, without any 
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differences in food intake. Efforts to (further) characterize metabolic phenotypes 
using protocols that involved single housing were stymied by a significant 
mortality rate for D2.1 KOs within several days, in part due to a refusal to eat.  
Whereas baseline (fed) core body temperature in D2.1 KOs was similar to L2.1 
KOs under group-housing condition, overnight-fasting during single-housing 
condition resulted in a dramatic reduction of body temperature in D2.1 KOs. 
Although also lacking hypothalamic InsR signals, I2.1 KOs did not exhibit similar 
phenotype as D2.1 KOs. This study highlighted the significance of the interactions 
between hypothalamic insulin- and leptin-sensing circuits in maintaining fasting 
body temperature, and the existence of multiple compensatory pathways in the 
central nervous system for thermoregulation (thermogenesis and social 
thermoregulatory behaviors) during energy deficit.  
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Introduction 
The ability to accurately gauge and respond to energy requirements is 
essential for maintaining energy balance. Neuronal circuits in the brain and 
periphery sense and integrate nutrient, hormonal and neuronal signals of energy 
status to direct a coordinated series of physiological processes regulating energy 
intake and expenditure (Schwartz et al. 1996; Shimizu et al. 1997; Baskin et al. 
1999; Porte et al. 2002; McMinn et al. 2004; Plum et al. 2005; Belgardt and 
Brüning 2010; Ring and Zeltser 2010; Moreno-Aliaga et al. 2011; Schwartz and 
Zeltser 2013). Beta cell-derived insulin and adipocyte-derived leptin relay signals 
of positive energy balance to neuronal populations distributed throughout the 
central nervous system (CNS) (Woods and Seeley, 2000). Patterns of 
fluctuations in plasma levels of these hormones are consistent with the idea that 
insulin provides short-term information about nutritional status, while leptin levels 
convey information about long-term energy stores. As obesity is associated with 
impaired sensitivity to both of these hormones, it is important to understand how 
these signals are transmitted and integrated under normal and 
pathophysiological conditions. 
Similarities between receptor distribution, intracellular signaling cascades 
and physiological effects of central leptin and insulin led to the proposal that 
interactions between networks sensing these signals provide an important 
mechanism for integration within homeostatic circuits (Baskin et al. 1999; 
Kulkarni et al. 1999; Xu et al. 2008). Leptin and insulin act on overlapping 
populations of neurons that are widely distributed, but highly concentrated in 
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hypothalamic and brainstem nuclei that regulate energy homeostasis (Baskin et 
al. 1983; Corp et al. 1986; Werther et al. 1987; Elmquist et al. 1998; Ahren and 
Havel 1999; Chen and Farese 2002; Fulton et al. 2006; Hommel et al. 2006; Xu 
et al. 2008; Myers et al. 2009; Scott et al. 2009; Hayes et al. 2010; Könner and 
Bruning 2012). In the central nervous system, both hormones activate similar 
signaling cascades including the phosphoinositide 3-kinase (PI3K) and mitogen-
activated protein kinase (MAPK) pathways to regulate energy intake (Ahren and 
Havel 1999; Bruning et al. 2000; Porte et al. 2002; Niswender et al. 2004; Fulton 
et al. 2006; Hommel et al. 2006; Belgardt and Brüning 2010; Hayes et al. 2010; 
Ring and Zeltser 2010; Schwartz and Zeltser 2013). Whereas insulin does not 
appear to stimulate signal transducer and activator of transcription 3 (STAT3) 
phosphorylation directly, it can potentiate leptin-induced STAT3 signaling (Barr et 
al. 1997; Shimizu et al. 1997; Baskin et al. 1999; Schwartz et al. 2000; 
Carvalheira et al. 2001; Air et al. 2002; Niswender et al. 2004; Komori et al. 
2005). While leptin and insulin signals may be integrated at the intracellular level 
in some types of neurons, there are also cases where leptin and insulin act on 
adjacent, but distinct neuronal subpopulations (Baskin et al. 1983; Corp et al. 
1986; Werther et al. 1987; Menéndez and Atrens 1991; Elmquist et al. 1998; 
Ahren and Havel 1999; Myers et al. 2009; Scott et al. 2009; Sanchez-Alavez et 
al. 2010; Williams et al. 2010; Könner and Bruning 2012). Finally, central 
injections of both leptin and insulin have been reported to increase energy 
expenditure and reduce food intake (Barr et al. 1997; Shimizu et al. 1997; Baskin 
et al. 1999; Schwartz et al. 2000; Air et al. 2002; Niswender et al. 2004; Xu et al. 
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2008).  
The hypothalamus is known to be one of the important sites of actions for 
insulin and leptin on energy metabolism and hypothesized site of interaction 
(Baskin et al. 1983; Corp et al. 1986; Werther et al. 1987; Schwartz et al. 1996; 
Shimizu et al. 1997; Elmquist et al. 1998; Ahren and Havel 1999; Baskin et al. 
1999; McMinn et al. 2004; Plum et al. 2005; Fulton et al. 2006; Hommel et al. 
2006; Myers et al. 2009; Scott et al. 2009; Belgardt and Brüning 2010; Hayes et 
al. 2010; Könner and Bruning 2012). In previous studies, we used Nkx2.1-Cre-
mediated recombination of a floxed Leptin receptor (Lepr) allele to investigate the 
role of hypothalamic LepRb signaling in energy balance (Ahren and Havel 1999; 
Kulkarni et al. 1999; Porte et al. 2002; Niswender et al. 2004; Belgardt and 
Brüning 2010; Ring and Zeltser 2010; Schwartz and Zeltser 2013). This 
approach broadly disrupted LepRb signaling in the hypothalamus, as well as in 
the lung, posterior pituitary, thyroid and neurons derived from Nkx2.1-expressing 
domains in the medial ganglionic eminence (Barr et al. 1997; Shimizu et al. 1997; 
Baskin et al. 1999; Schwartz et al. 2000; Carvalheira et al. 2001; Air et al. 2002; 
Chen and Farese 2002; Niswender et al. 2004; Komori et al. 2005; Xu et al. 
2008). However, it preserved signaling in midbrain and hindbrain nuclei that have 
been implicated in mediating some of leptin’s effects on food intake and energy 
expenditure (Baskin et al. 1983; Corp et al. 1986; Werther et al. 1987; Menéndez 
and Atrens 1991; Elmquist et al. 1998; Ahren and Havel 1999; Bruning et al. 
2000; Fulton et al. 2006; Hommel et al. 2006; Myers et al. 2009; Scott et al. 
2009; Hayes et al. 2010; Sanchez-Alavez et al. 2010; Williams et al. 2010; 
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Könner and Bruning 2012). From birth to until 8 weeks of age, Nkx2.1-Cre Lepr 
knockout (L2.1 KO) mice are indistinguishable from the global Lepr knockout 
(Leprdb/db) and develop similar degrees of hyperphagia, adiposity, and insulin 
resistance. After 8 weeks of age, Leprdb/db progressively gain adiposity and are 
unable to adapt to a cold challenge throughout adulthood, L2.1 KOs over 8 weeks 
of age maintain stable levels of body fat and develop adaptive thermogenesis 
(Ring and Zeltser 2010).  
L2.1 KO mice exhibit marked peripheral insulin resistance and 
hyperinsulinemia, raising the possibility that increased central insulin signaling 
could act to limit the severity of thermogenic-related deficits and adiposity. 
Consistent with this idea, hyperinsulinemic leptin-deficient Lepob/ob mice have 
increased baseline levels of hypothalamic phosphorylated-protein kinase B (p-
Akt) (Barr et al. 1997; Shimizu et al. 1997; Bruning et al. 2000; Schwartz et al. 
2000; Air et al. 2002; Niswender et al. 2004; Komori et al. 2005), a downstream 
target of insulin receptor signaling. Insulin injections into the anterior or 
mediobasal hypothalamus have been reported to increase brown adipose tissue 
(BAT) thermogenesis and metabolic rate, respectively (Menéndez and Atrens 
1991; Bruning et al. 2000; Sanchez-Alavez et al. 2010). In theory, stable levels of 
adiposity in L2.1 KO could reflect the direct actions of insulin signals within and/or 
outside the hypothalamus or the potentiation of extrahypothalamic leptin signals. 
To begin to investigate the nature of interactions between leptin- and insulin-
sensing brain networks, we compared metabolic and neuroendocrine phenotypes 
of mice with Nkx2.1-Cre-mediated disruption of InsR (I2.1 KO), LepRb (L2.1 KO), 
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or both receptors (double knockout, D2.1 KO).	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Methods 
Generation of I2.1, L2.1 and D2.1 KO mice 
To generate mice with genetic deficiency of Insr and/or Lepr in the 
hypothalamus, the Nkx2.1-Cre driver line (C57BL/6J-Tg(Nkx2-1-cre)2Sand/J, 
provided by S. Anderson, Weill Cornell Medical College) (Xu et al. 2008; Zhang 
et al. 2011; Bartfai and Conti 2012) was crossed to mice homozygous for a 
floxed allele of Lepr (FVB.BKS(D)-Leprdb/ChuaJ, provided by S. Chua, Albert 
Einstein College of Medicine) (McMinn et al. 2004; Ring and Zeltser 2010). The 
resulting F1 heterozygotes (Nkx2.1-Cre; Leprfl/+) were crossed to mice 
homozygous for a floxed allele of Insr (B6.129S4(FVB)-Insrtm1Khn/J, provided by 
D. Acilli, Columbia University Medical Center) (Kulkarni et al. 1999; Saito et al. 
2003; Streijger et al. 2009) to generate F2 Nkx2.1-Cre;Lepr fl/+;Insr fl/+ and Lepr 
fl/+;Insr fl/+ mice. F2 Lepr fl/+;Insr fl/+ mice were intercrossed to generate F3 
Leprfl/fl;Insrfl/fl females, which were then crossed to F2 Nkx2.1-Cre; Lepr fl/+;Insr fl/+ 
males to generate our experimental animals: Nkx2.1-Cre;Leprfl/fl (L2.1 KO), 
Nkx2.1-Cre;Insrfl/fl (I2.1 KO), Nkx2.1-Cre;Leprfl/fl;Insrfl/fl (D2.1 KO), and Leprfl/fl;Insrfl/fl 
(control) in a Mendelian ratio. Due to the low probability of achieving the desired 
genotypes in the offspring, two crosses were generally required to generate one 
conditional knockout male. Mouse genotypes were assessed by PCR on 
genomic DNA from tail tips using the following primers:  
Cre 
5’ GCGGTCTGGCAGTAAAAACTATC 3’ (forward)  
5’ GTGAAACAGCATTGCTGTCACTT 3’ (reverse)  
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Lepr  
5’ GTCTGATTTGATAGATGGTCTT 3’ (forward)  
5’ AGAATGAAAAAGTTGTTTTGGGA 3’ (forward)  
5’ GGCTTGAGAACATGAACAC 3’ (reverse) 
 
Insr 
5’ TGCACCCCATGTCTGGGACCC 3’ (forward)  
5’ GCCTCCTGAATAGCTGAGACC 3’ (reverse)  
 
Animal husbandry  
Mice were maintained in a temperature- and light-controlled environment 
(22°C ± 1°C; 12-hour light/12-hour dark cycle). Except where noted, mice were 
housed in sex-matched groups of 2–4 with at least 1 L2.1KO, 1 D2.1 KO, and 1 
control animal per cage. Pregnant and nursing mice were housed no more than 1 
dam per cage. Pups were weaned on postnatal day 21. Unless otherwise noted, 
mice had ad libitum access to chow (9% calories from fat, 5058 Mouse diet 20; 
Labdiet) and water until the time of sacrifice. For studies the involved single-
housing, mice were singly-housed for 2-3 weeks before experiments were done. 
All procedures were performed in accordance with the guidelines of the 
Institutional Animal Care and Use Committee at Columbia University Health 
Sciences Division. 
Preservation of adipose tissue depots  
At the time of sacrifice, animals were anesthetized with 2.5% Avertin, 0.02 
ml/g i.p. before cervical dislocation. Brown adipose tissue (BAT) was weighed, 
dissected and preserved in Allprotect tissue reagent (Qiagen). White adipose 
tissue depots were fixed overnight and processed for paraffin embedding. Five 
micron-thick sections were stained with hematoxylin and eosin and 200X images 
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were acquired using (Nikon Eclipse 80i equipped with a Retiga EXi camera and 
X cite 120 fluorescent illumination system). Images were converted into a binary 
format and analyzed with ImageJ with an adapted analysis method (Chen and 
Farese 2002; Cannon and Nedergaard 2004). At least four images across each 
adipose tissue sample were acquired and a total of three to four animals from 
each group were analyzed.  
Analysis of body composition  
To determine body composition, mice were subjected to nuclear magnetic 
resonance imaging (the Minispec, Bruker).  
Measurement of glucose, insulin, and leptin levels 
All blood samples were collected between 10 am and noon. Fasting blood 
samples were taken following 14–16 hours of fasting with ad libitum access to 
drinking water. Whole blood for glucose levels was taken via tail nick and 
assayed using a glucometer with disposable test strips (Abbott). The upper limit 
of measurement was 500 mg/dl; any “HI” readings were recorded as 501 mg/dl. 
Serum for insulin and leptin assessment was collected via orbital sinus puncture 
of isoflurane-anesthetized animals. Blood was collected and clotted at room 
temperature for one hour then centrifuged; serum was decanted and stored at –
20°C until used in leptin (Millipore) or insulin (Millipore) ELISA, per the 
manufacturer’s protocol.  
Indirect calorimetry and food intake 
Oxygen consumption and food intake were measured simultaneously 
using a 16-cage Indirect Calorimetry System combined with Feeding Monitor and 
	  	   61 
TSE ActiMot system (TSE-Systems). Oxygen consumption was measured using 
a paramagnetic O2 sensor over a 24-hour period. 
Measurement of food intake in group-housed animals 
2-3 mice of the same genotype were placed in each cage with food 
hoppers filled with pre-weighed food. The amount of food remaining in the 
hopper was measured every 2-3 days. Averaged daily food intake was calculated 
based on the number of days between measurements and the number of mice in 
each cage.  
Measurement of core body temperature  
Core body temperature was measured by a rectal temperature probe 
thermometer (Thermoworks) between 10am to noon. Baseline measurements 
were obtained under ad libitum feeding conditions; fasted readings were 
recorded after an overnight fast of 12-16 hours. During short-term cold challenge, 
mice fasted overnight were subjected to cold by placing in a glass beaker 
submerged in ice for 75 minutes. Body temperature was then assessed every 15 
minutes. 
Real-Time Quantitative PCR 
Total RNA was isolated from BAT that had been stored in Allprotect tissue 
reagent using the RNeasy Plus Universal kit (Qiagen). Reverse transcription was 
achieved using Transcriptor First Strand cDNA Synthesis kit (Roche). 
Quantitative PCR was done on a LightCycler 480 system (Roche) using the 
LightCycler 480 SYBR Green I Master. Expression levels for Ucp1 (forward, 5’ 
GTGAAGGTCAGAATGCAAGC 3’; reverse, 5’ AGGGCCCCCTTCATGAGGTC 
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3’) were normalized against Beta actin (forward, CGCCACCAGTTCGCCAT; 
reverse, CTTTGCACATGCCGGAGC) using the delta delta CT method.  
Statistics 
Data are presented as group mean ± SEM. Statistical comparisons were 
performed between sex- and age- matched groups using 2-tailed, unpaired 
Student’s t test or 1-way ANOVA with Bonferroni post-hoc analysis. P value of 
0.05 or less was considered to be statistically significant.  
	  	   63 
Results 
Nkx2.1-Cre-mediated loss of InsR signaling exacerbates body weight and 
adiposity phenotypes of L2.1 KOs  
Consistent with findings from mice lacking neuronal InsR signaling  
(NIRKO mice) (Menéndez and Atrens 1991; Schwartz et al. 1992; Bruning et al. 
2000; Leona Plum 2006), body weight and adiposity in I2.1 KO males were not 
different from controls (Figure 2.1A, B). Body weight and adiposity were 
significantly higher in L2.1 KO and D2.1 KO males as compared to I2.1 KO and 
controls starting from 6 weeks (Figure 2.1A, B). As we previously reported, 
adiposity in L2.1 KO males stabilized after 8 weeks of age (Luquet et al. 2005; 
Ring and Zeltser 2010). In contrast, body weight and adiposity of D2.1 KO started 
to diverge from L2.1 KO at 10 weeks (2.1A, B). At week 14, the adiposity of D2.1 
KO males was significantly higher (7%) than L2.1 KO males (Figure 2.1B). 
Female I2.1 KO mice weighed the same as the controls, but exhibited a 
mild increase (~2%) in adiposity starting from 10 weeks of age (Figure 2.1D, E), 
similar to observations in NIRKO females (Schwartz et al. 1992; Bruning et al. 
2000). Both L2.1 KO and D2.1 KO females had significantly higher body weight and 
adiposity than I2.1 KO and controls from 6 weeks of age (Figure 2.1D, E). 
Although L2.1 KO and D2.1 KO females had similar body weights throughout the 
study (Figure 2.1D), adiposity of the D2.1 KO females started to diverge from L2.1 
KO from 9 weeks (Figure 2.1E); however, increased adiposity in D2.1 KO females 
was not reflected in higher leptin levels at 12 weeks (Figure 2.1F).  
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 As gonadal fat depots were reported to be preferentially affected in 
NIRKO females (Coyle et al. 2002), we performed histological analyses of 
inguinal and gonadal fat depots in L2.1 KO and D2.1 KO females. Gonadal 
adiposity in D2.1 KO females was significantly increased as compared to L2.1 KO 
females at 9 and 19 weeks (increased by 40% and 34%, respectively). This 
difference was associated with an increase in adipocyte size in gonadal, but not 
inguinal, fat pads (Figure 2.2A-D). This result supported the idea that the 
increase in gonadal fat pad weights in D2.1 KO was at least partially due to 
increased adipocyte cell size (increased by 14% at 9 weeks and 24% at 19 
weeks as compared with L2.1 KO).  
Nkx2.1-Cre-mediated loss of InsR signaling does not exacerbates impaired 
glucose homeostasis of L2.1 KOs  
Whereas I2.1 KO males and females had the same blood glucose and 
serum insulin levels as controls, L2.1 KO and D2.1 KO males and females were 
hyperglycemic and hyperinsulinemic (Figure 2.3A-D). Despite the elevated 
adiposity in D2.1 KO vs. L2.1 KO males, fasting or fed blood glucose (Figure 2.3A), 
and serum insulin (Figure 2.3B) were similar in both groups. On the other hand, 
fed blood glucose was significantly higher (Figure 2.3C) and serum insulin 
trended higher (Figure 2.3D) in D2.1 KO females as compared to L2.1 KO at 12 
weeks.  
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Energy expenditure is decreased in D2.1 KO vs. L2.1 KO, while food intake is 
similar 
 Next, we sought to ascertain whether increased energy intake and/or 
decreased energy expenditure contributes to the increased adiposity in D2.1 KO 
vs. L2.1 KO mice. To this end, males in both groups were singly-housed in their 
home cages with food hoppers or in metabolic cages at 8 weeks of age. In either 
type of cage environment, approximately 30% of singly-housed D2.1 KO males 
died within 3-5 days, likely due to a dramatic suppression of food intake (light 
purple curve, Figure 2.4A). To overcome the high mortality rate of single-housing 
in D2.1 KO males, intake from food hoppers was assessed under group-housing 
conditions, with two to three mice of the same genotype in a cage. I2.1 KO males 
and females consumed the same amount of food as controls (Figure 2.4C). L2.1 
KO and D2.1 KO males and females were hyperphagic at both 5 and 10 weeks of 
age as compared to controls, but did not differ from each other (Figure 2.4C). 
Oxygen consumption during the light and the dark cycles was decreased by 
approximately 16% in D2.1 KO compared to L2.1 KO males, although it did not 
reach significance (Figure 2.4B). Together, these observations are consistent 
with the idea that changes in energy expenditure, but not food intake, contribute 
to increased body weights and adiposity in D2.1 KO mice.  
Nkx2.1-Cre-mediated loss of InsR signals from L2.1 KO increases fasting-
induced loss of core body temperature 
 As central leptin and insulin signaling have been implicated in regulating 
body temperature (Hill et al. 2010; Zhang et al. 2011; Bartfai and Conti 2012) and 
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we observed a trend toward decreased energy expenditure in D2.1 KOs, we 
explored whether the deficits in thermoregulation might contribute to the high 
mortality rate of singly-housed D2.1 KOs. To this end, we assessed the ability of 
L2.1 KO and D2.1 KO males to maintain body temperature in response to an 
overnight fast under group- and single-housing conditions. As we previously 
determined that L2.1 KO mice acquire the capability to thermoregulate in response 
to short-term cold challenge by 6 weeks (Cuendet et al. 1975; Ring and Zeltser 
2010), these studies were performed in males older than 8 weeks of age. When 
the mice were group-housed, fasting induced a larger decrease in core body 
temperature in D2.1 KO than all other groups (Figure 2.5A). Furthermore, fasting-
induced loss in core body temperature was significantly increased in D2.1 KO by 
single-housing condition (Figure 2.5B: D2.1 KO group -2.9±0.2°C vs. single -
4.9±0.6°C). Some singly-housed D2.1 KOs lost as much as 8-12°C, close to the 
approximately 7-10°C threshold associated with death (Saito et al. 2003; 
Streijger et al. 2009). Consistent with the increased loss of body temperature 
phenotype under fasted conditions, BAT Ucp1 expression in fasted singly-
housed D2.1 KOs was 18% lower than L2.1 KOs (Figure 2.5C). Single-housing was 
associated with increased loss in body temperature in response to fasting in I2.1 
KO and L2.1 KOs, but it did not reach significance (Figure 2.5B: I2.1 KO group -
0.8±0.7°C vs. single -1.6±0.4°C; L2.1 KO group -1.7±0.3°C vs. single -2.6±0.6°C).  
 Since body temperature has to be regulated in response to different types 
of stressors, we also looked at the ability of L2.1 KO and D2.1 KO to 
thermoregulate during a short-term acute cold challenge. Although body 
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temperature was dramatically decreased in singly-housed D2.1 KOs in response 
to fasting at room temperature (Figures 2.5A, B), D2.1 KOs (fasted overnight 
before subjected to the cold challenge) were able to maintain stable body 
temperature during the cold challenge (Figure 2.6). All groups (including the D2.1 
KOs, which had significantly lower body temperature at the beginning of the test) 
showed an increase in body temperature initially when subjected to the cold. The 
elevated body temperature of D2.1 KO and L2.1 KO were similar, but both groups 
had significantly lower temperature when compared with controls throughout the 
experiment.  
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Discussion 
Increased adiposity in D2.1 KO is due to decreased energy expenditure 
 As central injections of insulin can suppress food intake and increase 
energy expenditure (Antoni 1993; Wotjak et al. 1996), the initial goal of our study 
was to explore whether hypothalamic insulin signaling contributes to the 
stabilization of adiposity levels seen in L2.1 KOs after 8 weeks of age (Redemann 
2010). To this end, we used Nkx2.1-Cre-mediated recombination to disrupt 
signaling via InsR and/or LepRb. Consistent with observations in mice lacking 
InsR signaling throughout the CNS (Duan et al. 2007), all measured metabolic 
parameters in I2.1 KO males were similar to controls, while older females 
exhibited mild increases in adiposity (Figure 2.1E). This failure to observe 
consequences of diminished InsR signals on parameters that are reportedly 
altered by central insulin injections (i.e. food intake, energy expenditure and 
lipogenesis), likely reflects the robust capacity for developmental compensation 
in circuits regulating energy balance (Kruse et al. 2003; Lin et al. 2008; Zelena 
2012).  
 Despite the fact that we could not detect changes in any metabolic 
parameters in I2.1 KO males, disruption of InsR signals in the L2.1 KO genetic 
background resulted in further increases in body weight and adiposity (Figure 
2.1B). Although central insulin can produce anorectic effects (Appenrodt et al. 
1998), increased obesity of D2.1 KO was not due to hyperphagia (Figure 2.4C), 
but decreased energy expenditure (Figure 2.4B). Preceding the changes in body 
weight and adiposity, oxygen consumption in D2.1 KO males was 16% less than 
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in L2.1 KO. This decreased in energy expenditure likely contributes to the 
increased weights and adiposity in older D2.1 KO animals (Bielsky et al. 2004). 
However, due to the high mortality rate of singly-housed D2.1 KO males in 
metabolic cages and the poor odds of generating a D2.1 KO male (one in two 
litters), we did not generate sufficient numbers for the difference to reach 
significance. It is interesting to note that insulin and leptin have opposite effects 
on POMC neuronal activity and removal of InsR signals on POMC neurons in 
Pomc-Cre Lepr knockout mice resulted in a significant reduction, rather than an 
increase, in fat mass and body weight (Liebsch et al. 1996; Wigger et al. 2004). 
Together with our data, these observations support the idea that InsR signals via 
non-POMC hypothalamic neurons contribute to the stabilization of body weight 
and adiposity in adult L2.1 KO mice.  
High mortality rate of D2.1 KOs under single housing conditions 
The most striking observation in our study was that ~30% of D2.1 KOs 
refused to consume food when singly-housed either in metabolic cages or in 
home cages with a food hopper (Figure 2.4A). It is unlikely that this aphagic 
response results from a failure to learn to eat from the food hopper, as all group-
housed D2.1 KOs consumed the same amount of food as L2.1 KOs (Figure 2.4C). 
As severe stress can elicit anhedonia (Engelmann et al. 2004; Zhang et al. 2012; 
reviewed in Schwartz and Zeltser), it is possible that increased stress axis 
reactivity in D2.1 KOs when confronted with a novel object (food hopper) in a 
novel environment (metabolic cage) contributes to the aphagic response. 
Consistent with this idea, we find that the response to fasting stress is elevated in 
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D2.1 KOs as compared to L2.1 KOs (Data are presented in Chapter 3). Aphagic 
D2.1 KOs typically died within 3 days, sooner than has been reported for obese 
Leprob/ob solely due to starvation (Luppino et al. 2011). Death was likely hastened 
by the inability of singly-housed D2.1 KOs to thermoregulate when fasted (Figures 
2.5A-B). 
Hypothalamic leptin and insulin signals interact to regulate body 
temperature in response to nutritional stress 
 Conserving energy by reducing body temperature promotes survival when 
food sources are limited. While leptin- and insulin-sensing neurons have been 
implicated in body temperature regulation (Sanchez-Alavez et al. 2010; Enriori et 
al. 2011), the degree to which these circuits interact is not known. Similar to 
Leprdb/db animals (McMinn et al. 2004), L2.1 KOs exhibit a 1-2oC decrease in 
baseline (fed) body temperature (Ring and Zeltser 2010) (Figure 2.5A). 
Disruption of LepRb signaling in AgRP and POMC neurons also leads to a 
similar decrease in baseline body temperature as Leprdb/db mice (van de Wall et 
al. 2008). Conversely, NPY deficiency (Erickson et al. 1996) and Pomc 
overexpression (Mizuno et al. 2003) in Lepob/ob mice normalize the reduced 
baseline body temperature. Together, these data are consistent with the idea that 
loss of leptin signals in the hypothalamus, likely involving some neuronal 
populations in the arcuate nucleus of the hypothalamus (ARH), is sufficient to 
direct thermoregulatory circuits to conserve energy. However, lower body 
temperatures of D2.1 KOs as compared to L2.1 KOs supports the hypothesis that 
leptin- and insulin-sensing circuits interact to maintain body temperature. In 
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theory, increased circulating insulin levels in L2.1 KOs could act to promote 
thermogenesis via actions on InsR in the hypothalamus. 
 In response to an overnight fast, group-housed D2.1 KOs exhibited 
significantly decreased core body temperature as compared to all other 
experimental groups (Figure 2.5A). Nevertheless, there was a further decrease in 
body temperature when D2.1 KOs were singly-housed (Figure 2.5B), suggesting 
that huddling might be masking the fasting-induced decreased thermogenesis in 
group-housed D2.1 KO. As L2.1 KOs are hyperinsulinemic even after an overnight 
fast (Figures 2.3B, D), it raises the possibility that hypothalamic InsR signals 
serve as important compensatory signals to maintain body temperature. The 
observation that core body temperature in fasted I2.1 KOs did not differ from 
controls is consistent with the idea that hypothalamic leptin signals, which are not 
decreased after an overnight fast, can compensate for the loss of InsR signals 
under these conditions. The dramatic loss of core body temperature in D2.1 KOs 
following an overnight fast supports the hypothesis that interactions between 
hypothalamic InsR and LepRb signals are critical to maintain body temperature 
under conditions of nutritional stress. Consistent with this idea, STZ-treated rats, 
which have dramatically reduced circulating leptin and insulin levels, also exhibit 
very low fasting body temperatures (Kinoshita et al. 2000). 
 While most analyses focus on the magnitude of fasting-induces decreases 
in body temperature, it should be noted that the capability to conserve energy in 
response to negative energy balance is maintained. The fact that fasted I2.1 KOs, 
L2.1 KOs and D2.1 KOs all decrease their body temperature in response to an 
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overnight fast, strongly supports the idea that other signals are sufficient to 
provide this input. For example, ghrelin is induced by fasting (Toshinai et al. 
2001) and is reported to suppress body temperature (Inoue et al. 2013). 
Redundancy in the signals that can direct thermoregulatory circuits to conserve 
energy likely reflects the importance of this adaptive strategy for survival. 
Dramatic reduction in core body temperature in D2.1 KO in response to 
fasting can be rescued by an acute cold challenge 
 Thermogenic adaption in response to environmental stressors is an 
important survival strategy for warm-blooded animals. Although L2.1 KOs and D2.1 
KOs have significantly lower core body temperatures when fasted at room 
temperature, they dramatically increased body temperature to baseline (fed) 
levels within 15 minutes of an acute cold challenge (Figure 2.6). These 
observations are consistent with the idea that circuits engaged by the cold 
exposure are intact in L2.1 KOs and D2.1 KOs. Shivering-thermogenesis mediated 
through the skeletal muscles (Cannon and Nedergaard 2011) could promote 
thermogenesis. In addition, LepRb and/or InsR signals outside the domain 
affected by Nkx2.1-Cre-mediated recombination could act to promote cold-
induced thermogenesis. 
Phenotypes of mouse models with loss or gain of LepRb signaling in 
different brain regions can provide some insights into central circuits regulating 
the response to a cold challenge. The inability of Lepob/ob and Leprdb/db to maintain 
body temperature in response to an acute challenge (Trayhurn and James 1978; 
McMinn et al. 2004) strongly implicates leptin signaling in this process. 
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Expressing the LepRb transgene in the CNS using rat synapsin I and/or neuron-
specific enolase enhancer/promoter completely normalized the cold tolerance in 
Leprdb/db animals (Kowalski et al. 2001; de Luca et al. 2005), consistent with the 
idea that the critical site(s) of leptin action are in the brain. Importantly, Nkx2.1-
Cre- (L2.1 KO) and Camk2a-Cre- mediated removal of LepRb do not recapitulate 
the cold intolerance observed in Leprdb/db (McMinn et al. 2005; Ring and Zeltser 
2010). 
These results are consistent with the idea that leptin-sensing neurons 
mediating cold-induced thermogenesis likely reside outside of the domains 
affected by the Nkx2.1-Cre (active in the ARH, ventromedial hypothalamus, 
dorsomedial nucleus of the hypothalamus (DMH), paraventricular nucleus of the 
hypothalamus (PVH), preoptic area (POA), but not in the parabrachial nucleus 
(PB), nucleus of the solitary tract (NTS) and periaqeductal grey (PAG)) and 
Camk2a-Cre (active in the ARH, VMH, DMH, PVH, POA, NTS and PAG, but not 
in the PB) transgenes. LepRb-sensing neurons in the DMH and median preoptic 
area (MnPOA) have been implicated in regulating sympathetic outflow to 
promote BAT thermogenesis (Zhang et al. 2011). Since leptin signaling in both of 
these is disrupted in Camk2a-Cre;Leprflox/flox and L2.1 KO mice, they are probably 
not critical to maintain body temperature in response to an acute cold challenge.  
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Identification of leptin-sensing neurons that promote the response to cold 
stressors is an important area for future research. Retrochiasmatic area and NTS 
are two regions that contain LepRb neurons retrogradely labeled by 
pseudorabies virus injected into BAT (Zhang et al. 2011) or skeletal muscle 
(Babic et al. 2010). Since neither Camk2a-Cre (McMinn et al. 2005) nor Nkx2.1-
Cre (Ring and Zeltser 2010) achieves recombination in these brain regions, 
these regions may contain the thermogenic leptin-sensing neurons that are 
responsible for the maintenance of body temperature during acute-cold challenge 
in L2.1 KO and Camk2a-Cre Lepr KO animals. Lepr is also expressed in several 
other regions implicated in body temperature regulation (i.e. PB and PAG) (Scott 
et al. 2009; Shaun F Morrison 2012) that do not express Camk2a-Cre or Nkx2.1-
Cre transgenes.  
	  	   75 
Conclusions 
Our results raise the possibility that the hyperinsulinemia may be a 
compensatory response to the development of obesity. While neonatal loss of 
AgRP neurons in mice leads to developmental compensatory to maintain normal 
feeding (Luquet et al. 2005), dysfunctions developed during adulthood such as 
obesity may trigger different types of compensatory consequences to maintain 
energy balance. Although initially important for temporary alleviation of the 
metabolic dsyregulation, chronic activation of the compensatory system, 
however, may eventually lead to adverse outcomes.  
The observation that D2.1 KO mice exhibited significantly greater fasting-
induced temperature loss than L2.1 KO highlights the importance of the integration 
of nutrient-related signals (e.g. leptin and insulin) to the central thermoregulatory 
circuits in regulating body temperature in response to nutrient stress. The fact 
that D2.1 KO can maintain their body temperature during acute cold challenge 
(when fasted) suggested that these mice can thermoregulate, but an appropriate 
thermoregulatory response were not triggered during fasting. And this phenotype 
was not secondary to obesity since D2.1 KO and L2.1 KO had similar adiposity 
when the study was conducted. These observations therefore raise the possibility 
that some comorbidities observed in obesity maybe independent of the increased 
fat mass and could be treated separately by targeting the specific pathway 
involved.  





Figure 2.1: Nkx2.1-Cre-mediated disruption of InsR signals exacerbates 
obesity of L2.1 KOs. (A) Body weight and (B) adiposity of male control, I2.1 KO, 
L2.1 KO, and D2.1 KO mice; n ≥ 10 for all groups at all time points. (C) Serum 
leptin, as measured by ELISA, at 8 and 12 weeks of male control, I2.1 KO, L2.1 
KO, and D2.1 KO mice; n ≥ 4 for all groups at all time points. (D) Body weight and 
(E) adiposity of female control, I2.1 KO, L2.1 KO, and D2.1 KO mice; n ≥ 9 for all 
groups at all time points for body weight. n ≥ 4 for all groups at all time points for 
adiposity. (F) Serum leptin at 8 and 12 weeks of female control, I2.1 KO, L2.1 KO, 
and D2.1 KO mice; n ≥ 4 for all groups at all time points. All data are mean ± SEM. 
P values were calculated between age- and sex-matched groups. (A-D) *P < 
0.05 L2.1 KO versus D2.1 KO;  #P < 0.05 I2.1 KO versus controls. (C, F) Lowercase 
letters above bars denote statistically similar (P > 0.05) groups.  
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Figure 2.2: Preferential increase in gonadal adiposity and adipocyte size in 
D2.1 KO females. (A, B) Gonadal and inguinal fat pad weights of control, L2.1 KO, 
and D2.1 KO females; (A) n ≥ 3 for all groups at 9 weeks of age and (B) n ≥ 7 for 
all groups at 19 weeks of age. (C, D) Average cross-sectional areas of gonadal 
and inguinal fat pad adipocytes, from histological sections, of control, L2.1 KO, 
and D2.1 KO females; (C) 9 weeks of age, n ≥ 3 for all groups; (D) 19 weeks of 
age, n ≥ 4 for all groups. All data are mean ± SEM. P values were calculated 
between age-matched groups. Lowercase letters above bars denote statistically 
similar (P > 0.05) groups.  


























Figure 2.3: Disruption of hypothalamic InsR signals does not exacerbate 
glucose impairment in male L2.1 KOs. (A, C) Whole-blood glucose at 6 (fasted), 
8 (random-fed), 10 (fasted) and 12 (random-fed) weeks of age in control, I2.1 KO, 
L2.1 KO, and D2.1 KO mice; (A) males, n ≥ 4 for all groups at all time points; (B) 
females, n ≥ 7 for all groups at all time points. (B, D) Serum insulin, as measured 
by ELISA, at 6 (fasted), 8 (random-fed), 10 (fasted) and 12 (random-fed) weeks 
of age in control, I2.1 KO, L2.1 KO, and D2.1 KO males (B) and females (D); n ≥ 3 
for all groups at all time points. All data are mean ± SEM. P values were 
calculated between age- and sex-matched groups. Lowercase letters above bars 
denote statistically similar (P > 0.05) groups.  
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Figure 2.4: Increased adiposity in D2.1 KOs is not due to effects on food 
intake. (A) Cumulative food intake, as measured in the metabolic cages of adult 
singly-housed male control, L2.1 KO, and D2.1 KO and D2.1 KO* (mice refused to 
eat). (B) Daily oxygen consumption (vO2), as measured in metabolic cages, of 
adult singly-housed male control, L2.1 KO, D2.1 KO and D2.1 KO; n ≥ 5 for all 
groups. Data presented for light cycle, dark cycle or 24 hour total. (C) Averaged 
daily food intake, at 5 and 10 weeks of age, of group-housed male and female 
controls, I2.1 KO, L2.1 KO, and D2.1 KO; n ≥ 3-4 for all groups at all time points. All 
data are mean ± SEM. P values were calculated between age- and sex-matched 
groups. Lowercase letters above bars denote statistically similar (P > 0.05) 
groups.  
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Figure 2.5: Disruption of hypothalamic InsR signals exacerbates fasting-
induced loss of body temperature in L2.1 KOs. (A) Core body temperature of 
group- and singly-housed, fed and fasted, control, I2.1 KO, L2.1 KO, and D2.1 KO 
adult males; n ≥ 4 for all groups. (B) Change in core body temperature of group- 
and singly-housed control, I2.1 KO, L2.1 KO, and D2.1 KO adult males in response 
to an overnight fast; n ≥ 4 for all groups. (C) BAT Ucp1 mRNA expression, as 
measured by quantitative PCR, of fasted singly-housed control, L2.1 KO, and D2.1 
KO adult males; n ≥ 4 for all groups. All data are mean ± SEM. (A) Lowercase 
letters above bars denote statistically similar (P > 0.05) body temperature of 
animals with the same genotype under different conditions (Fed-group, Fed-
single, Fasted-group and Fasted-single). *P < 0.05 for statistical difference 
between different groups (control, I2.1 KO, L2.1 KO, and D2.1 KO) under the same 
condition. (B-C) Lowercase letters above bars denote statistically similar (P > 
0.05) groups under the same condition. *P < 0.05 for statistical difference of 
animals with the same genotype under fed versus fasted condition.  
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Cold Challenge





































Figure 2.6: L2.1 KO and D2.1 KO males can mount a thermogenic response to 
an acute cold challenge. (A) Body temperature during short-term cold 
challenge of control, L2.1 KO, and D2.1 KO adult males; n ≥ 4 for all groups. All 
data are mean ± SEM. *P < 0.05 L2.1 KO and D2.1 KO versus controls;  #P < 0.05 
D2.1 KO versus control.  
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CHAPTER 3: “Hypothalamic Insulin-sensing Circuit Regulates Activity of 
the HPA Axis in Response to Stress.” 
Introduction  
 The higher prevalence of (hypothalamic-pituitary-adrenal) HPA axis 
dysregulation and mood disorders such as depression and anxiety in both type 1- 
and type 2-diabetes raise the possibility that decreased insulin signaling may 
contribute to the development of these disorders (Shaban et al. 2006; Bruehl et 
al. 2007; Li et al. 2008; Khuwaja et al. 2010; Torres et al. 2013). Intranasal insulin 
attenuated HPA axis activation (diminished saliva and plasma cortisol) in humans 
subjected to a psychological stressor (Bohringer et al. 2008; Zarkovic et al. 
2008). In rodents, streptozotocin (STZ)-induced diabetes leads to increased 
circulating corticosterone (CORT) levels and corticotropin-releasing hormone 
(Crh) expression in the paraventricular nucleus of the hypothalamus (Tronche et 
al. 1999; Chan et al. 2001), suggesting hyperactivation of the HPA axis. These 
studies thus raised the possibility that central insulin signals may be involved in 
suppressing HPA axis activity. During the metabolic characterization of 
hypothalamic leptin receptor and insulin receptor double knockout (D2.1 KO) mice 
in Chapter 2, we noted a high mortality rate when D2.1 KO were single-housed. 
The search for the causes of death in D2.1 KO led us to uncover an increase in 
activity of the HPA axis, suggesting that hypothalamic insulin-sensing circuit 
could provide negative regulation to the HPA axis. The following manuscript in 
preparation describes our effort to study the HPA axis function in the various 
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Nkx2.1-Cre mediated hypothalamic knockout animals (I2.1 KO, L2.1 KO, D2.1 KO), 
as well as the neurobehavioral functions in I2.1 KO mice.  
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CN Angie Chong, Alexis S Hill, Lori M Zeltser, Rene Hen 
Abstract  
In our previous study using Nkx2.1-Cre mediated condition knockouts of 
leptin receptor (L2.1 KO), insulin receptor (I2.1 KO) and both receptors (double KO, 
D2.1 KO), we noticed a high mortality rate in D2.1 KOs, in part due to a refusal to 
eat, within a few days during single-housing studies in the metabolic cages, an 
environment with both social isolation and novelty stress. These types of stress 
have been shown to increase hypothalamic-pituitary-adrenal (HPA) axis 
sensitivity and induce anorexia in mice respectively. We examined the fasting-
induced response in singly-housed D2.1 KO mice and found that their 
corticosterone (CORT) levels were significantly elevated as compared to L2.1 KO 
mice. Evaluation of I2.1 KO mice, which had normal body weight and adiposity, 
also revealed an increase in stress-induced HPA axis activity. These 
observations in InsR-deficient I2.1 KO and D2.1 KO mice suggested that 
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hypothalamic InsR signals are involved in regulating HPA axis activity. In 
humans, diabetes and HPA axis dysregulation are often associated with 
psychiatric disorders such as depression and anxiety disorders, we therefore 
decided to further investigate the neuro-behavioral functions and found that I2.1 
KOs exhibited increased anxiety-like behaviors in open field, marble burying, and 
stress-induced hyperthermia tests. Our results provide evidence to support a role 
of hypothalamic insulin signals in suppressing HPA axis activity and some 
anxiety-like behaviors in mice.  
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Introduction 
Insulin levels decrease during fasting, and upon feeding, its levels 
increase. This fluctuation in circulating insulin in relations to feeding status is 
opposite to that of corticosterone (CORT) levels, which is dramatically increased 
by fasting and reduced by refeeding (Poplawski et al. 2010). During fasting (a 
type of metabolic stress), the increased CORT and decreased insulin levels allow 
activation of metabolic pathways (e.g. hepatic gluconeogenesis) (Renga et al. 
2012) that provide the substrates to meet the specific energetic demands of the 
body. Similarly, CORT released during psychological stress (e.g. restraint in 
rodents) increases glucose availability in preparation for a possible flight and fight 
response (Munck et al. 1984). Interestingly, insulin levels are also upregulated 
during restraint stress (Warne 2009), but the function of this increase is not 
known.  
 CORT release is mainly regulated by the hypothalamic-pituitary-adrenal 
(HPA) axis. Upon activation of the HPA axis by stress, corticotropin-releasing 
hormone (CRH) and arginine vasopressin (AVP) are released from hypothalamic 
neurons into the anterior pituitary, where these hormones increase 
adrenocorticotropic hormone (ACTH) release. ACTH stimulates the adrenal 
cortex to secret CORT. Several studies suggested that insulin may play a role in 
suppressing HPA axis activity. Diabetic animal models (e.g. streptozotocin (STZ)-
induced diabetic mice) exhibit hyper-activation of HPA axis with elevated ACTH 
and CORT levels; while insulin replacement restored the levels of these 
hormonal to normal (Chan et al. 2003; Engeland and Arnhold 2005). Similarly in 
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humans, patients suffering from diabetes mellitus often exhibit hypercortisolemia 
(Ferrini et al. 1999; Bruehl et al. 2007). Observations from both rodents and 
human studies are consistent with the idea that sufficient insulin signals are 
required for reducing HPA axis activity. However, as chronic stress and elevated 
circulating glucocorticoid levels can induce systemic insulin resistance and 
increase insulin levels (Zarkovic et al. 2008), it is still not clear whether elevated 
glucocorticoid levels promote the development of insulin resistance and diabetes 
or vice versa. In addition, both diabetes and HPA dysregulation are often 
associated with affective disorders including anxiety and depression (Bruehl et al. 
2007; Kallen et al. 2008), suggesting that a common underlying pathway may 
contribute to the development of these disorders.  
Preliminary studies on animals that lack hypothalamic leptin receptor 
(LepRb) and/or Insulin receptor (InsR) signals suggested that the interactions 
between these hypothalamic signals provide negative regulation of HPA axis 
activity. When comparing to mice that lack only hypothalamic LepRb signaling 
(L2.1 KO), mice that lack both hypothalamic LepRb and InsR signals (Double KO, 
D2.1 KO) exhibit heightened HPA axis response to fasting. This observation raises 
the possibility that hypothalamic insulin signals suppress HPA axis activation 
under some circumstances. Since Both L2.1 KO and D2.1 KO mice exhibited 
severe obesity, hyperphagia, hyperinsulinemia, hyperglycemia, and 
hypercorticosteronemia, the analysis of the HPA axis functions on top of the 
metabolic dysregulation was very challenge (for metabolic characterization of the 
different mutants used in this study, please refer to Chapter 2). Therefore, to 
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understand the role of hypothalamic insulin signals in modulating HPA axis 
function and neuro-behaviors, we generated I2.1 KO mice that lack InsR signaling 
in the majority of the hypothalamus mice by crossing mice with floxed alleles of 
Insr to Nkx2.1-Cre driver animals. Since I2.1 KO did not exhibit any major changes 
in body weight, adiposity and glucose metabolism, they present a better model 
for understand the role of hypothalamic InsR signals in regulating stress axis.  
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Methods 
Generation of I2.1, L2.1 and D2.1 KO mice 
 To generate conditional knockouts of Insr and/or Lepr, the Nkx2.1-Cre 
driver line (C57BL/6J-Tg(Nkx2-1-cre)2Sand/J, provided by S. Anderson, Weill 
Cornell Medical College) (Xu et al. 2008) was crossed to mice homozygous for a 
floxed allele of Lepr (FVB.BKS(D)-Leprdb/ChuaJ, provided by S. Chua, Albert 
Einstein College of Medicine) (McMinn et al. 2004). The resulting F1 
heterozygotes (Nkx2.1-Cre; Leprfl/+) were crossed to mice homozygous for a 
floxed allele of Insr (B6.129S4(FVB)-Insrtm1Khn/J, provided by D. Acilli, Columbia 
University Medical Center) (Kulkarni et al. 1999) to generate F2 Nkx2.1-Cre;Lepr 
fl/+;Insr fl/+ and Lepr fl/+;Insr fl/+ mice. F2 Lepr fl/+;Insr fl/+ mice were intercrossed to 
generate F3 Leprfl/fl;Insrfl/fl females, which were then crossed to F2 Nkx2.1-Cre; 
Lepr fl/+;Insr fl/+ males to generate our experimental animals: Nkx2.1-Cre;Leprfl/fl 
(L2.1 KO), Nkx2.1-Cre;Insrfl/fl (I2.1 KO), Nkx2.1-Cre;Leprfl/fl;Insrfl/fl (D2.1 KO), and 
Leprfl/fl;Insrfl/fl (control) in a Mendelian ratio. Due to the low probability of 
achieving the desired genotypes in the offspring, two crosses were generally 
required to generate one conditional knockout male. Mouse genotypes were 
assessed by PCR on genomic DNA from tail tips using the following primers:  
Cre  
5’ GCGGTCTGGCAGTAAAAACTATC 3’ (forward)  
5’ GTGAAACAGCATTGCTGTCACTT 3’ (reverse)  
Lepr  
5’ GTCTGATTTGATAGATGGTCTT 3’ (forward)  
5’ AGAATGAAAAAGTTGTTTTGGGA 3’ (forward)  
5’ GGCTTGAGAACATGAACAC 3’ (reverse) 
Insr 
5’ TGCACCCCATGTCTGGGACCC 3’ (forward)  
5’ GCCTCCTGAATAGCTGAGACC 3’ (reverse)
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Animal husbandry 
Mice were maintained in a temperature- and light-controlled environment 
(22°C ± 1°C; 12-hour light/12-hour dark cycle). Pups were weaned on postnatal 
day 21. Unless otherwise noted, mice had ad libitum access to chow (9% 
calories from fat, 5058 Mouse diet 20; Labdiet) and water until the time of 
sacrifice. In the single-housing experiment, mice were single-housed 2-3 weeks 
before experiments were done. All procedures were performed in accordance 
with the guidelines of the Institutional Animal Care and Use Committee at 
Columbia University Health Sciences Division. 
Preservation of hypothalamus and pituitary 
At the time of sacrifice, animals were anesthetized with 2.5% Avertin,  
0.02 ml/g i.p., before cervical dislocation. Hypothalamus (whole hypothalamus; 
paraventricular nucleus; median eminence) and pituitary were dissected out and 
frozen in liquid nitrogen immediately.  
Measurement of serum corticosterone levels 
Serum was collected from tail bleeds on minimally-stressed animals 
unless otherwise stated. Baseline (fed) blood samples were collected between 
10 am and noon. Fasting blood samples were taken following 14–16 hours of 
fasting with ad libitum access to drinking water. Blood was collected and clotted 
at room temperature for one hour then centrifuged. Serum was decanted and 
stored at –20°C until used in CORT radioimmunoassay (MP Biomedicals) in the 
laboratory of S. Wardlaw (Columbia University, New York, New York, USA). 
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Quantitative RT-PCR  
Total RNA was isolated from fresh frozen hypothalamus and pituitary 
using the RNeasy Plus Universal kit (Qiagen). Reverse transcription was 
achieved using Transcriptor First Strand cDNA Synthesis kit (Roche). 
Quantitative PCR was done on a LightCycler 480 System (Roche) using the 
LightCycler 480 SYBR Green I Master. Target genes were normalized against 
Beta actin.  
Primers Sequence:  
 
Beta actin (β-actin) 
forward, 5’ CGCCACCAGTTCGCCAT 3’ 
reverse, 5’ CTTTGCACATGCCGGAGC 3’ 
Arginine vasopressin (Avp)  
forward, 5’ ACTACCTGCCCTCGCCCTGC 3’ 
reverse, 5’ GCCACGCAGCTCTCGTCGCT 3’ 
Corticotropin-releasing hormone (Crh) 
forward, 5’ AGGAGGCATCCTGAGAGAAGT 3’ 
reverse, 5’ CATGTTAGGGGCGCTCTC 3’ 
Propiomelanocortin (Pomc)  
forward, 5’ GCAACCTGCTGGCTTGCATCCG 3’ 
reverse, CCGAAGCGGTCCCAGCGGAA 3’ 
Glucocorticoid receptor (Gr) 
forward, 5’ ACTTCGCAGGCCGCTCAGTGTT 3’  
reverse, 5’ TGGTCCCGTTGCTGTGGAGGAGC 3’ 
 
Restraint Stress Response  
Mice were placed in a 50-ml falcon tubes for 30 minutes. Tail blood was 
sampled at 0, 30 (end of restraint), and 60 minutes (after restraint) after the 
beginning of a restraint. Serum was collected as previously described.  
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Psychiatric Evaluations 
Open Field Test (OF) 
After one-hour acclimation to the testing room, mice were placed in the 
open field arena for 30 minutes. Open field tests were videotaped for scoring 
later. Total distance traveled, and ratio of time spent in the periphery and center 
of the field were recorded and used to evaluate the anxiety levels in rodents 
(Walsh and Cummins 1976).  
Novelty Suppressed Feeding (NSF) 
The novelty suppressed feeding test is a paradigm used to assess 
anxiety-like behavior in novel environment (Santarelli et al. 2003). In preparation 
for this test, animals were fasted overnight. During the test, animals were placed 
in a brightly lit box (30 cm x 40 cm) with bedding on the floor and an accessible 
food pellet tied down to a circle of Whatman paper in the center of the box. In this 
test, anxiety was measured based on the time it took an animal to enter the 
brightly lit center of the arena and to bite the food pellet.  
Marble Burying Test (MB)  
The marble-burying test was used for measuring anxiety- and obsessive-
compulsive-disorder-like behaviors in rodents. Mice were placed in a cage filled 
with 4-5cm of wood chip bedding, and 12 marbles, evenly spaced, were placed 
on top of the bedding. The duration of the each test was 20 minutes. The number 
of marble buried in the bedding was recorded. Increased in marbles buried 
indicates increased anxiety-like behaviors (De Boer and Koolhaas 2003).  
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Stress-Induced Hyperthermia (SIH) 
Stress-induced hyperthermia was used to measure the physiological 
change of body temperature (about 0.5-2oC) after encountering stress. It has 
been used as a model to assess non-behavioral change in rodents due to 
anxiety. The stressors we used in this test were the handling and used of rectal 
probe to measure the core body temperature of the mice at baseline. 
Temperature was then measured again with a rectal temperature probe 
thermometer (Thermoworks) after 60 minutes (Bouwknecht et al. 2007). 
Forced swimming Test (FST) 
The forced swimming test was conducted with mice using a modification 
of established procedures that are used to evaluate antidepressant drugs. Swim 
sessions were conducted placing mice in individual beakers (46 cm tall x 32 cm 
in diameter) containing 23° - 25°C water 30 cm deep. Two swim sessions were 
conducted, always between 12:00 and 18:00 hours: an initial 6 min pretest 
followed 24 hours later by a 6 min test. Mice were continuously monitored while 
swimming. Swim sessions were videotaped for scoring later (Castagné et al. 
2011). 
Statistics  
Data are presented as group mean ± SEM. Statistical comparisons were 
performed between sex-matched groups using 2-tailed, unpaired Student’s t test 
or 1-way ANOVA with Bonferroni post-hoc analysis. P value of 0.05 or less was 
considered to be statistically significant.  
	  	   102 
Results 
Loss of hypothalamic InsR signals does not affect baseline CORT levels 
Since female sex hormones are known to influence activity of the HPA 
axis (Ferrini et al. 1999), we limited our analysis in this study to male mice. The 
lowest (baseline) levels of CORT are observed during the morning, at around 
10am (a few hours after the beginning of the light cycle) (Engeland and Arnhold 
2005), in mice. There was no difference in CORT levels between I2.1 KO and 
control mice. While both L2.1 KO and D2.1 KO had significantly elevated baseline 
CORT as compared to I2.1 KO and controls, they were not different from each 
other (Figure 3.1A). The loss of hypothalamic InsR signals on wild type or L2.1 KO 
background did not affect baseline HPA axis activity. Since single-housing (social 
isolation) has been shown to alter stress response (Bartolomucci et al. 2003; 
Williams et al. 2009; Niwa et al. 2013), a separate group of mice were subjected 
single-housing prior to the assessment of HPA axis activity. Consistent with what 
was reported by other groups, single-housing did not influence baseline HPA axis 
activity (Figure 3.1A). 
Increased HPA axis activity after restraint in I2.1 KO mice 
Restraint (immobilization) stress is one of the commonly used tests for 
evaluating sensitivity of HPA axis to psychogenic (non-physical) stress in 
rodents. Since changes in basal HPA axis activity dramatically influence the 
dynamics of CORT response to stress in rodents (Windle et al. 1998; Hotchkiss 
et al. 2004; Pankevich et al. 2010), we mainly made comparison between I2.1 KO 
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and controls (exhibited similar baseline CORT levels), and L2.1 KO and D2.1 KO 
(Figure 3.1A, L2.1 KO and D2.1 KO had similarly elevated baseline CORT).  
Control and I2.1 KO mice subjected to a 30-minute restraint showed normal 
initiation of CORT response, but a further increase in CORT levels after the 
restraint as compared to controls (Figure 3.1B). Since mice carrying the Cre 
transgene alone did not show an overall change in response to restraint when 
compared to wild-type animals (data not shown), the altered stress response in 
I2.1 KO was likely due to the loss of InsR signals mediated by Nkx2.1-expressing 
neurons. The initial CORT response to restraint in L2.1 KO and D2.1 KO was about 
2-folds higher than both I2.1 KO and the controls, but the response was not 
different between L2.1 KO and D2.1 KO (Figure 3.1B). Similar to I2.1 KO, loss of 
hypothalamic InsR signals (from the L2.1 KO background) led to an increase, 
though did not reach significance, in CORT after restraint in D2.1 KO mice.  
Single-housing did not influence baseline activity of the HPA axis (Figure 
1A), but similarly increased the initial CORT response to restraint stress in all 
groups of animals (Figure 3.1C). This is consistent with other studies which 
detected increased stress response, but not baseline HPA axis activity, in singly-
housed mice (Bartolomucci et al. 2003). Unlike during group-housing, we did not 
detect higher CORT levels in I2.1 KO after restraint (as compared to controls) 
(Figure 3.1B,C).  
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Altered gene expression of HPA axis components in I2.1 KO  
To find the neuroendocrine changes that might contribute to the elevated 
HPA axis activity in I2.1 KO mice, we evaluated gene expression and peptide 
levels of several major HPA axis components in the hypothalamus and pituitary. 
Hypothalamic gene expression and median eminence (ME) peptide levels were 
assessed at various time points: 0 (baseline), 30 (end of restraint), and 60 (30min 
after restraint) minutes. Although usually considered the major driver of HPA axis 
activity, hypothalamic Crh expression (Figure 3.2E) and CRH levels in the ME 
(Figure 3.2A) were not changed. On the contrary, both Avp mRNA expression 
(Figure 3.2F) and AVP levels in the ME (Figure 3.2B) were significantly increased 
by 53% and 18% respectively at baseline in I2.1 KO. Furthermore, while ACTH 
levels in the pituitary remained the same (Figure 3.2C), pituitary Pomc 
expression was increased at 60 minutes (Figure 3.2G). These findings were 
consistent with the elevated CORT levels observed in the I2.1 KO after restraint 
(Figure 3.1B). Since GR signaling in the hypothalamus and pituitary can 
negatively regulate the stress axis (Tasker and Herman 2011; Jeanneteau et al. 
2012), we assessed Gr expression in both regions. We detected a 30% decrease 
in hypothalamic glucocorticoid receptor (Gr) expression at 30 minutes in I2.1 KO 
(Figure 3.2D). Gr in the pituitary, however, was increased at 30 minutes (Figure 
3.2H), suggesting a possible compensatory mechanism for counteracting the 
hypothalamic changes.  
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Increased fasting-induced corticosterone release in D2.1 KO Mice 
The observed elevated HPA axis activity in I2.1 KO mice after restraint led 
us to further examine the fasting-induced CORT response in the mutants.  
Since CORT and insulin levels are reciprocally regulated by energy status 
(Poplawski et al. 2010) and STZ-induced diabetes leads to increased CORT and 
Crh expression in the paraventricular nucleus of the hypothalamus (PVH) (Chan 
et al. 2001), we explored the idea that hypothalamic insulin signals regulate 
fasting-induced CORT release. In group-housed environment, we detected a 
trended, but non-significant, increase in CORT levels in I2.1 KO as compared to 
controls. Fasting CORT levels also trended higher in D2.1 KO as compared to L2.1 
KO mice during group-housed. Interestingly, CORT levels in D2.1 KOs were 
significantly higher than L2.1 KO in single-housing condition (Figure 3.3A). Fasting 
hypothalamic expression of Avp, but not Crh and Gr, in group-housed D2.1 KO 
and L2.1 KO was significantly higher than both I2.1 KO and controls (Figure 3.3B). 
Similarly to what was observed during restraint stress, single-housing 
environment significantly increased fasting-induced CORT response in I2.1 KO 
and controls (Figure 3.3A), consistent with the idea that single-housing 
environment increases sensitivity of HPA axis to stress. 
Increased anxiety-like behaviors in I2.1 KO  
Both HPA axis dysregulation and diabetes are often associated with 
psychiatric diseases such as anxiety and depression in humans (Bruehl et al. 
2007; Kallen et al. 2008; Zelena 2012), and HPA axis hyperactivity is also 
consistently found in patients with anxiety disorders (Appenrodt et al. 1998; 
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Flandreau et al. 2012). In light of the observed increased HPA axis in I2.1 KO 
mice, we performed various neuro-behavioral tests in order to evaluate the 
anxiety and depression levels in these mice.  
Anxiety-Like Behaviors  
Open field test (OF), novelty-suppressed feeding (NSF), marble burying 
(MB) and stress-induced hyperthermia (SIH) tests were used to evaluate anxiety-
like behaviors in our mice. In OF, I2.1 KO mice showed a significant decrease in 
locomotor activities after 20 minutes in the field (Figure 3.4A). However, no 
change in the number of entries to the center of the field was observed (Figure 
3.4D). In MB, we did not detect any baseline changes. However, after stress, I2.1 
KO showed an increase in number of marble buried as compared to controls, 
suggesting an increase in anxiety-like behaviors (Figure 3.4B). Since I2.1 KO mice 
showed a change in locomotor activities in OF, which sometimes complicates the 
interpretation of an anxiety phenotype in rodents, we decided to further assess 
the anxiety-like behaviors with tests that are less dependent on the levels of 
physical activities: novelty-suppressed feeding test (NSF) and stress-induced 
hyperthermia (SIH) (Bielsky et al. 2004; Vinkers et al. 2008). NSF assesses the 
anxiety levels of a fasted animal by the latency to feed in a novel environment, 
and increased latency indicates an increase in anxiety-levels. I2.1 KO showed a 
trended non-significant increase in latency in feeding (Figure 3.4C). During 
stress-induced hyperthermia (SIH), an anxiety response that is mediated by the 
autonomic nervous system, and a larger induction of body temperature by the 
stressor indicates increased anxiety levels. I2.1 KO exhibited higher body 
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temperature than the controls 60 minutes after the probe insertion stress (Figure 
3.4E). Together, these results suggested there was an increase in anxiety-like 
behaviors in I2.1 KO mice. 
Depressive Behaviors 
Forced swim test (FST) is a type of learned helplessness test used to 
assess depression levels of rodents (Castagné et al. 2011). Experimental 
animals were placed in a beaker with water, from which they could not escape. 
The level of depression was indicated by the time of the animals spent immobile, 
without attempting to escape or swim during the 6-minute test. We did not detect 
any change in I2.1 KO during the test session (Figure 3.4F). I2.1 KO mice did not 
seem to exhibit depressive-like behaviors.  
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Discussion 
Interactions between hypothalamic InsR and LepRb signals regulate HPA 
axis activity in response to metabolic and psychogenic stress 
Psychogenic Stress (Restraint) 
In the current study, we showed that group-housed I2.1 KO mice had 
increased HPA axis activity after restraint (Figure 3.1B), but not during fasting 
(Figure 3.3A). Comparing restraint CORT response in L2.1 KO and D2.1 KO also 
revealed a similar (trended) increase in HPA axis activity in D2.1 KO mice (Figure 
3.1B). I2.1 KO mice also exhibited increased baseline AVP, but not CRH levels 
(Figure 3.2). These results raise the possibility that elevated AVP release may 
underlie the alteration in HPA axis activity of I2.1 KOs as treatment of pituitary 
cells by AVP have been shown to decrease sensitivity to glucocorticoid negative 
feedback (Aguilera 1994).  
Efforts to further understand the underlying cause of the increased HPA 
axis activity in I2.1 KO by looking at expression levels of hypothalamic genes 
(Crhr1, Crhr2, Avpr1a, Avpr1b, Gr, Ucn1, Ucn2, Ucn3, data not shown) 
implicated in regulating stress response revealed that Gr expression was 
decreased in I2.1 KO (Figure 3.2D). Since the hypothalamus has been shown to 
mediate the glucocorticoid negative feedback, (Nathan K Evanson 2010; Tasker 
and Herman 2011; Laryea et al. 2012), the decreased Gr (possibly GR signal) 
could provide an alternative explanation for the hyperactivity in HPA axis after 
restraint stress. Either the increased baseline AVP or decreased hypothalamic Gr 
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expression observed in I2.1 KO is consistent with the idea that hypothalamic 
insulin signals are involved in the negative feedback of stress response. 
The decrease in Pomc (baseline) and increase in Gr (30 minutes) 
expression in the pituitary (Figure 3.2G, H) likely represent compensatory 
responses to suppress the enhanced HPA axis activity due to the hypothalamic 
changes. This could provide a possible explanation for the relatively mild 
increase in CORT levels in I2.1 KO despite the ~70% increase in pituitary Pomc 
expression (after restraint). Since glucocorticoids have been shown to suppress 
ACTH release from the pituitary (Dayanithi and Antoni 1989), the effect of 
increased pituitary Pomc synthesis on ACTH release could be partially corrected 
by the increased pituitary GR signals.  
The elevated hypothalamic Avp expression in in I2.1 KOs (Figure 3.2F) 
suggested that hypothalamic InsR signals may directly regulate transcription in 
AVP neurons; we do not know the exact site(s) of the AVP neurons being 
affected in I2.1 KOs since they are found in multiple hypothalamic nuclei 
(suprachiasmatic nucleus (SCN), supraoptic nucleus (SON) and PVH). Given our 
observation that AVP levels in the median eminence were increased (Figure 
3.2B), the involved AVP neuronal population likely resides in PVH or/and SON, 
since both populations release AVP to the median eminence (Antoni 1993; 
Wotjak et al. 1996). Supporting this idea, female mice with decreased forkhead 
box protein O1 (FOXO1) signaling in PVH (similar to the effect of increased InsR 
signals) exhibited a trended decrease in hypothalamic Avp expression, and 
FOXO1 was also shown to directly decrease promoter activity of the Avp gene 
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(Redemann 2010). Although further studies will be needed to determine if 
hypothalamic InsR signals directly regulate the functions of AVP neurons in the 
PVH as well as how the increased AVP levels may contribute to the decreased 
negative feedback, existing data (including ours) suggested that hypothalamic 
InsR signals on PVH AVP neurons may be important for down-regulating HPA 
axis activity after encountering a psychogenic (restraint) stress. 
Metabolic Stress (Fasting) 
An overnight fast resulted in a trended increase in serum CORT levels in 
group-housed D2.1 KO as compared to L2.1 KO (Figure 3.3A). Interestingly, during 
single-housing condition, D2.1 KOs exhibited significantly higher fasting CORT 
levels than L2.1 KOs (Figure 3.3A), suggesting that hypothalamic InsR signals are 
important in suppressing fasting-induced HPA axis in the absence of 
hypothalamic LepRb signals, since I2.1 KO had similar CORT levels to the 
controls under the same condition.  
Elevated fasting CORT levels in L2.1 KO as compared to the control 
animals suggested that hypothalamic LepRb signal may be involved in regulating 
fasting-induced activity of HPA axis (Figure 3.3A). A significant elevation in 
fasting hypothalamic Avp, but not Crh, expression in L2.1 KO raises the possibility 
that Avp synthesis is also regulated by hypothalamic LepRb signals. This 
observation is consistent with the elevated hypothalamic Avp expression 
reported in Lepob/ob mice, which was suppressed by leptin treatment (Duan et al. 
2007). These data raise the possibility that the suppressive effect of 
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hypothalamic LepRb signals on fasting-induced response might be mediated by 
AVP neurons in the hypothalamus.  
 Together, our data suggested that during restraint, hypothalamic insulin 
signal influences glucocorticoid negative feedback, and hypothalamic leptin 
signals seem to regulate baseline and the initial activation of the HPA axis. 
During fasting state, interactions between hypothalamic InsR and LepRb signals 
negatively regulate the HPA axis. And hypothalamic InsR signal alone seemed to 
be less important in suppressing this response, likely due to the low level of 
insulin signaling during fasting.  
Increased hypothalamic AVP may underlie the increased anxiety-like 
behaviors in I2.1 KO mice 
Other than stimulating the HPA axis, AVP has also been shown to 
increase anxiety levels. In human, elevated AVP levels have been implicated in 
the development of anxiety- and depressive- like symptoms (Kruse et al. 2003; 
Lin et al. 2008; Zelena 2012); while injecting AVP into rats increases anxiety 
levels (Appenrodt et al. 1998). Consistently, Avpr1a knockout mice showed 
reduced anxiety-like behaviors (Bielsky et al. 2004). In the CNS, AVP neurons in 
the hypothalamus have been suggested to influence anxiety levels in rodents. 
Rat bred for higher anxiety levels have elevated Avp mRNA in the PVH, and rats 
experienced maternal separation also exhibited increase activation of 
hypothalamic AVP neurons and anxiety levels (Liebsch et al. 1996; Wigger et al. 
2004; Zhang et al. 2012). Therefore, the elevated hypothalamic Avp expression 
could be responsible for the increased anxiety-like phenotypes observed in I2.1 
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KO (Figure 3.4). Interestingly, the increase in anxiety-like behaviors in I2.1 KO 
was only detected after an initial stressful event (in OF, novel environment; MB, 
saline injection; SIH, probe insertion), and at a later time-course. The timing 
when the anxiety-like behaviors was observed therefore raised the possibility that 
the anxiety-like phenotypes in I2.1 KO might be secondary to the decreased 
negative feedback and elevated CORT levels as acute CORT treatment can 
induce increased anxiety-like behaviors (Mitra and Sapolsky 2008). However, the 
exactly relationship between the increased activity in HPA axis and behavioral 
changes in I2.1 KO is not known. 
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Conclusions 
 In this study, we have provided evidence for a novel role of hypothalamic 
insulin signals in modulating the negative feedback of the HPA axis, as well as 
anxiety-like behaviors in mice. Nevertheless, the exact sites of InsR signals that 
are mediating these effects, as well as the AVP neuronal population that might 
contribute to the elevated HPA axis activity and increased anxiety-like behaviors 
are not known. Since Nkx2.1-Cre is not only expressed in the hypothalamus, but 
also in interneurons of the striatum and cerebral cortex, neurons of the globus 
pallidus and septum, as well as the amygdala, and some of these regions are 
implicated in the development of anxiety disorders, we cannot eliminate the 
possibility that the observed phenotypes were due to the loss of InsR signals in 
these extra-hypothalamic regions. Moreover, the exact mechanism of how 
hypothalamic insulin regulates AVP levels is also not known. One possible 
mechanism, as discussed earlier, is that insulin signaling in the PVH may directly 
regulate Avp expression through FOXO1-mediated transcriptional pathway.  
 In humans, since metabolic syndrome is often associated with anxiety and 
other psychiatric disorders (Luppino et al. 2011), understanding the contribution 
of central insulin resistance to these disorders might therefore allow the 
development of more effective treatments for psychiatric disorders in these 
patients, which often makes the management of metabolic syndrome more 
difficult. Although the study of I2.1 KO suggested a possible link between central 
insulin resistance, stress axis dysfunction and anxiety disorders, further studies 
will be needed to understand the exact relationship between the loss of InsR 
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signaling in Nkx2.1- expressing neurons, and the alterations in HPA axis and 
behavioral outcomes.   
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Figure 3.1: Loss of hypothalamic InsR signals resulted in increased CORT 
response to restraint.	  (A) Baseline (fed) serum CORT levels in adult group- and 
single-housed males; n ≥ 7 for all groups at all time points. (B) Serum CORT 
levels at baseline, at the end of a 30min restraint (indicated by arrow) and 30min 
after restraint in adult group-housed males; n ≥ 12 for I2.1 KO and controls, n ≥ 3 
for L2.1 KO and D2.1 KO, at all time points. (C) Serum CORT levels at baseline, at 
the end of a 30min restraint (indicated by arrow) and 30min after restraint in adult 
single-housed males; n ≥ 4 for all groups at all time points. All data are mean ± 
SEM of control, I2.1 KO males, L2.1 KO and D2.1 KO. (A) Lowercase letters above 









































































Figure 3.2: Altered gene expression of HPA axis components at baseline 
and during restraint test in I2.1 KO. (A) CRH and (B) AVP protein levels in the 
median eminence; (E) Crh and (F) Avp mRNA expression levels in the 
hypothalamus at baseline, at the end of restraint (30min), and 30min post-
restraint; n ≥ 5 for all groups at all time points. (C) ACTH protein levels and (G) 
Pomc mRNA in the pituitary;n ≥ 4 for all groups at all time points. (D) 
Hypothalamic, and (H) pituitary Gr mRNA; n ≥ 4 for all groups at all time points. 
All data are mean ± SEM of control and I2.1 KO males. *P < 0.05 control versus 

























































































































































































Figure 3.3: Loss of hypothalamic InsR signls resulted in increased CORT 
response to fasting in single-housed D2.1 KO. (A) Fasting serum CORT levels 
in adult group- and single- housed males; n ≥ 4 for all groups at all time points. 
(B) Avp, Crh and Gr mRNA expression levels in the hypothalamus of fasted 
group-housed animals; n ≥ 3 for all groups at all time points. All data are mean ± 
SEM of control, I2.1 KO males, L2.1 KO and D2.1 KO. Lowercase letters above bars 
denote statistically similar (P > 0.05) groups. *P < 0.05 for statistical difference 

























































Figure 3.4: Defective behavioral responses in I2.1 KO. (A) Total distance 
travelled and (D) number of entries to the center, in each 5-minute bin during the 
open field test (OF); n ≥ 9 for all groups. (B) Number of marbles buried during a 
20min marble burying test (MB) at baseline and after stress; n ≥ 9 for all groups. 
(C) Latency to feed during novelty-supressed feeding (NSF) test; n ≥ 9 for all 
groups. (E) Stress-induced hyperthermia (SIH): body temperature at baseline 
and 60 min after stress; n ≥ 9 for all groups. (F) Time spent immoble during a 
6min forced-swim test (FST); n ≥ 9 for all groups. All data are mean ± SEM of 
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CHAPTER 4: CONCLUDING REMARKS  
Hypothalamic leptin receptor long isoform (LepRb) and insulin receptor 
(InsR) signals have been largely studied independently for their roles in 
regulating energy intake and expenditure, yet little is known about their 
interactions to modulate energy balance. Hypothalamic leptin signals can 
compensate for some of insulin’s function in glucose metabolism in insulin-
deficient mice (Fujikawa et al. 2013). On the other hand, it’s not known if 
hypothalamic InsR signals can similarly compensate for some of leptin’s 
functions. We therefore tested the hypothesis that hypothalamic InsR provides 
compensatory signals in L2.1 KO (hypothalamic Lepr knockout) animals to 
regulate energy metabolism by using the D2.1 KO model, which lacks LepRb and 
InsR signals in the majority of the hypothalamus.  
From the study of the D2.1 KO mice (Chapter 2), we have shown that the 
hypothalamic InsR signals in L2.1 KO mice influence energy expenditure and 
adiposity, in part through effects on body temperature. The failure to observe 
similar phenotypes in I2.1 KO (hypothalamic Insr knockout) mice is likely due to 
the compensatory actions of hypothalamic leptin signals to promote energy 
expenditure and thermoregulatory responses, while suppressing HPA axis 
activity. Strikingly, single-housing led to increased mortality rate and severe 
thermogenic dysregulation in D2.1 KO, but not in L2.1 KO mice, suggesting the 
interactions between environmental factors and the underlying genetic defects 
influence phenotypic outcomes in these mice.  
In order to focus our study on the effects of loss of hypothalamic InsR on 
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the stress axis, we used I2.1 KO mice as a model (Chapter 3). Unlike D2.1 and L2.1 
KO mice, which are hypercorticosteronemic, I2.1 KO mice do not exhibit major 
metabolic or HPA axis disturbances at baseline. Nevertheless, we found that the 
loss of hypothalamic InsR signals resulted in impaired negative feedback to 
stress response and some anxiety-like behaviors. Since the obese and insulin 
resistant state is associated with increased stress reactivity and anxiety disorders 
in humans, results from our studies support the idea that central insulin 
resistance might contribute to the observed HPA axis dysregulation and anxiety 
disorders in obesity.  
Modification of phenotypic outcomes by the interactions between 
environmental and genetic factors 
The dramatic effect of single-housing was first observed when D2.1 KO 
animals were singly-housed for food intake or energy expenditure (in metabolic 
cages) studies. A significantly number of D2.1 KO died in the middle of the study 
and the deaths were associated with a refusal to eat (Figure 2.4A). Since stress 
can induce anorexia in mice (Saegusa et al. 2011), the aphagic response in 
some D2.1 KO during single-housing could be a result of increased stress 
response induced by the novel environment, which was then further exacerbated 
by the social isolation. Although being obese and hyperglycemic, L2.1 KO did not 
exhibit similar mortality rates during the same studies. Therefore, we further 
examined why single-housing was causing significant mortality in the D2.1 KOs.  
Strikingly, single-housing brought out a dramatic body temperature 
phenotype in fasted D2.1 KO, which was not observed in L2.1 KO (Figure 2.5A), 
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consistent with the idea that hypothalamic InsR and LepRb interact to maintain 
body temperature in a state of negative energy balance via effects on brown 
adipose tissue (BAT) thermogenesis. InsR signals in the preoptic area (POA) 
inhibit the warm-sensing neurons, and activate the thermogenic pathways in BAT 
(York et al. 1985; Moriscot et al. 1993; Sanchez-Alavez et al. 2010). Similarly, 
LepRb signaling in the DMH mediates leptin’s effect on BAT thermogenesis 
(Enriori et al. 2011). Theoretically, increased InsR signaling in the POA of 
hyperinsulinemic L2.1 KOs could partially compensate for the loss of thermogenic 
hypothalamic LepRb signals. Thus, the loss of both hypothalamic leptin and 
insulin signals (as in D2.1 KO) would severely impair BAT thermogenesis and the 
ability to thermoregulate.  
The single-housing condition led to significantly greater fasting-induced 
loss in body temperature in D2.1 KO, but not in L2.1 KO, I2.1 KO or the control mice 
(Figure 2.5A). Environmental factors, such as ambient temperature, are known to 
have a great impact on the thermoregulatory system in small rodents such as 
mice, which need to devote a large fraction of its energy metabolism to maintain 
body temperature (Shaun F Morrison 2012). Mechanisms to thermoregulate in 
mice range from the less energy costly mechanisms such as vasoconstriction, 
pilorection, and behavioral changes (e.g. changes in postures, huddling, etc.) to 
those that require more energy such as non-shivering adaptive and shivering 
thermogenesis. Mice housed at normal ambient temperature (~22oC, most 
housing facilities) exhibit higher BAT Ucp1 as compared with those at 
thermoneutrality (~30oC) (Chen et al. 2003), indicating an increase in BAT 
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thermogenesis at sub-thermoneutral housing temperature.  
As mentioned earlier, huddling is a social thermoregulatory behavior and 
increased huddling is observed in mice housed at lower ambient temperature 
(Canals and Bozinovic 2011). Higher BAT thermogenesis is also observed in 
singly-housed mice as compared to those that are group-housed at the same 
ambient temperature (Jennings et al. 1986). These studies support the idea that 
mice housed at either temperature below thermoneutrality and/or in isolation 
would require additional BAT thermogenic activity to maintaining body 
temperature. Therefore, the dramatic loss of fasting body temperature in singly-
housed D2.1 KO mice could be a result of the inability of these mice to provide the 
additional BAT thermogenesis (due to the lack of thermogenic hypothalamic 
LepRb and InsR signals). To minimize the impact of social isolation on 
physiological functions in rodents (Bartolomucci et al. 2003), we performed a 
subsequent study in which all mice were group-housed until the day when they 
were subjected to an overnight fast in single-housing. Their body temperature 
was then measured after the fast at the beginning of the light cycle. We allowed 
the mice to recover for a week, and repeated the same fasting experiment in 
group-housing condition. Consistent with what we reported in mice that were 
single-housed for two to three weeks (Figure 2.5A), in this experiment, fasting 
body temperature of D2.1 KOs was significantly lower than L2.1 KOs in both 
housing environments (Figure 4.1). Comparing body temperature of D2.1 KOs and 
L2.1 KOs in group- versus single-housing environment revealed a significantly 
lower temperature in single-housed D2.1 KO (as compared to group-housed), but 
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not in L2.1 KOs. These results therefore further supported the idea that in group-
housed D2.1 KO mice, huddling can partially compensate for the deficit in BAT 
thermogenesis associated with fasting.  
The dramatic reduction in body temperature in singly-housed D2.1 KOs 
was only observed during fasting (energy deficit) also raise the possibility that 
these mice were in a torpor state, a hypometabolic state generally defined as a 
regulated reduction in core body temperature below 31oC (Gluck et al. 2006). 
However, since torpor in fasted mice has been reported to occur more frequently 
in group- than single- housed mice (Webb et al. 1982), and single-housing 
increased the proportion of D2.1 KO mice exhibiting fasting body temperature 
lower than 31oC (data not shown), the dramatically reduced body temperature in 
D2.1 KO during fasting is unlikely to represent a true torpor state. So, the high 
mortality rate in single-housed D2.1 KO might be a result of enhanced stress 
response, which was further exacerbate by a failure to thermoregulate, and 
eventually lead to death if the aphagia persist for several days. 
 These observations highlight the importance of thermoregulatory 
behaviors, in addition to BAT thermogenesis, for regulating body temperature. 
The consequences of housing animals below thermoneutrality for body weight 
and energy expenditure phenotypes have been the subject of several recent 
review (Speakman and Keijer 2012). For example, housing Ucp1 knockout mice 
in thermoneutrality, but not at normal ambient temperature, increased 
susceptibility of the knockouts to high-fat-diet-induced obesity (Enerback et al. 
1997; Feldmann et al. 2009). Our data highlight the need to consider differences 
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between single- and group-housing conditions as well, particularly in animals with 
impaired thermoregulatory circuits. Another observation that highlights the 
dramatic influence of housing environment on experimental outcomes is the 
increased CORT response to both restraint and fasting in I2.1 KO and control 
mice when singly-housed (Figure 3.1, 3.3), which is consistent with what has 
been reported in wild type mice by Bartolomucci et al. (Bartolomucci et al. 2003). 
Nevertheless, increased fasting CORT response was not observed in singly-
housed D2.1 KO and L2.1 KO (both lacking hypothalamic LepRb), suggesting a 
differential interaction between single-housing and this genetic mutation. 
Interactions between single-housing (social isolation stress) and genetic 
factors have been reported in several different mouse models. Adolescent social 
isolation of animals with a putative dominant-negative DISC1 (disrupted in 
schizophrenia 1) under the expression control of a prion protein promoter exhibit 
behavioral phenotypes that were not seen in mice with either the genetic or the 
environmental component alone (Niwa et al. 2013). There was also an increase 
in CORT levels in the socially isolated mutants, and the effect of social isolation 
on the phenotypes was blocked by glucocorticoid receptor II antagonist (Pilkis 
and Granner 1992; Rebuffé-Scrive et al. 1992; Niwa et al. 2013), supporting the 
idea that social isolation causes dysregulation of the HPA axis. Together with our 
study, these results supported the idea that interactions between housing 
environment and certain genetic factors can bring out or mask a phenotype.  
 The influence of social isolation stress (a very commonly used housing 
condition) on the functions of HPA axis would be potentially problematic for many 
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studies focusing on energy metabolism since activation of HPA axis exerts 
systemic effects on multiple target organs including the liver, skeletal muscles, 
and adipose tissue (Pilkis and Granner 1992; Rebuffé-Scrive et al. 1992; Liu et 
al. 2010), etc. to influence body fat distribution, fuel metabolism and energy 
partitioning. And the observed phenotypes in an animal model may therefore be 
secondary to their differences in stress response to the housing condition.  
Future Directions 
Since the singly-housed fasted D2.1 KO exhibit significantly lower body 
temperature and higher serum CORT levels (Figure 2.5A, 3.3A), and CORT can 
suppress BAT thermogenesis in both wildtype and Lepob/ob animals (York et al. 
1985; Moriscot et al. 1993; Nonogaki et al. 2007), it raises the possibility that the 
increased CORT might contribute to the reduction in fasting body temperature in 
D2.1 KO mice. In order to investigate the effect of elevated CORT on BAT 
thermogenesis, we can perform adrenalectomy (ADX) on both L2.1 KO and D2.1 
KO mice and then clamp their circulating glucocorticoid levels (by peripheral 
replacement) at a similar level. If the fasting temperature phenotype persists, 
elevated CORT levels in D2.1 KO unlikely underlie the phenotype. If the 
phenotype is corrected, we could further explore the contribution of peripheral 
versus central GR signals in the dampening of thermogenesis in D2.1 KO with 
central GR-II antagonist administration. Normalizing the fasting-induced 
decreases in body temperature in D2.1 KO by ADX and peripheral glucocorticoid 
replacement, but not by central injections of GR-II antagonist alone, would be 
consistent with the idea that the increase in peripheral GR signals contributes to 
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the body temperature phenotype. Either if central or peripheral GR signaling is 
responsible for the decreased temperature, site- (specific brain nucleus) or 
tissue- (liver, white adipose tissue, brown adipose tissue, skeletal muscles) 
specific removal of GR signals by viral-mediated knockdown of Gr in D2.1 KO can 
then be used to identify the site(s) of action of glucocorticoid that is mediating this 
effect. 
Possible contributions of glucocorticoids to increased adiposity in D2.1 KOs 
While D2.1 KO males have higher body weights and adiposity than L2.1 KO 
starting from 8 weeks, I2.1 KO mice are the same as the controls (Figure 2.1A, B). 
These observations support the idea that interactions between hypothalamic 
InsR and LepRb are involved in adiposity and body weight regulation. The 
increased adiposity in D2.1 KO is not due to changes in food intake, but likely 
decreased energy expenditure, supported by a trended decrease in oxygen 
consumption (Figure 2.4B: ~16% lower than L2.1 KO, P ~ 0.09). Our current n 
number in this study was 5 mice in each genotype. Given the high variability in 
oxygen consumption and mortality rate during the metabolic cages study in the 
D2.1 KO mice, approximately 20 more mice in each genotype would be needed to 
obtain significance in our result and therefore this arm of the study was not 
further pursued.  
Another factor that could contribute to the increased adiposity in D2.1 KO is 
the increased circulating CORT levels. D2.1 KO exhibit a 25% increase in baseline 
CORT (Figure 3.1A, although this difference is not statistically significant), and a 
significantly increase in fasting CORT response, as compared to singly-housed 
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L2.1 KO (Figure 3.3A). Increased circulating glucocorticoids levels have been 
shown to promote increase adiposity. Either chronic stress or exogenous 
glucocorticoid treatments have been shown to increase adiposity, and gonadal 
fat distribution in rats (Rebuffé-Scrive et al. 1989; Makimura et al. 2000; Fujikawa 
et al. 2013); while adrenalectomy reduces obesity in Lepob/ob mice (Makimura et 
al. 2000; Wigger et al. 2004). In human studies, women with increased visceral 
obesity have been shown to exhibit hyperactive HPA axis (York et al. 1985; 
Moriscot et al. 1993; Strack et al. 1995; Pasquali et al. 2002, 1996). These 
studies suggested that elevated glucocorticoids could underlie the preferential 
gain in gonadal, but not inguinal, adiposity in D2.1 KO mice (Figure 2.1, 2.2).  
Future Directions 
We could investigate the extent to which elevated CORT levels underlie 
the increased adiposity in D2.1 KOs vs. L2.1 KOs by adrenalectomy (ADX) and 
then replacing with defined amounts of glucocorticoids. By clamping circulating 
levels of glucocorticoids in both D2.1 KO and L2.1 KO mice from 8 weeks when 
their adiposity started to diverge, we could detect adult changes in adiposity that 
are not due to a difference in glucocorticoid levels. On the contrary, ADX and 
clamping the glucocorticoid levels early during post-weaning development at a 
similar level, and then varying the levels of replacement in D2.1 KO (higher levels) 
and L2.1 KO (lower levels) in adulthood will allow us to determine if differences in 
adult glucocorticoid levels are sufficient for the development of the increased 
adiposity in D2.1 KO mice. Alternatively, we could also raise circulating 
glucocorticoid levels in L2.1 KO by exogenous CORT administration to that of 
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similar to D2.1 KO and study the effect on adiposity. If raising circulating 
corticosterone levels in L2.1 KO resulted in an adiposity level similar to that of D2.1 
KOs, it would then suggested that increased glucocorticoid levels contributed to 
the difference in adiposity between L2.1 KO and D2.1 KO. 
The role of central InsR signals in regulating stress response and anxiety  
From our studies, we have shown that the loss of InsR signals in the 
majority of the hypothalamic neurons led to increased activity of HPA axis (in D2.1 
KO and I2.1 KO) and a mild increase in anxiety-like behaviors (in I2.1 KO). 
However, the exact relationship between the HPA axis dysregulation and 
anxiety-like behaviors in I2.1 KO is not known. Given the data we collected so far, 
we came up with a few possible explanations for the observed phenotypes in I2.1 
KO mice: central insulin signals acting on different neuronal populations (circuits) 
to influence HPA axis activity and anxiety-like behaviors; insulin acts on 
hypothalamic neurons (maybe AVP neurons) that are common regulators for 
both the HPA axis activity (by projecting to the median eminence) and anxiety 
behaviors (by projecting to other brain regions); increased anxiety in I2.1 KO is a 
result of increased central GR signaling (due to increased circulating CORT 
levels). 
 Since Nkx2.1-Cre is not only expressed in the hypothalamus, but also in 
interneurons of the striatum and cerebral cortex, neurons of the globus pallidus 
and septum, as well as the amygdala (Xu et al. 2008), and some of these regions 
are also implicated in the development of anxiety disorders (Appenrodt et al. 
1998; Shepard et al. 2000), we cannot completely eliminate the possibility that 
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the observed phenotypes were due to the loss of InsR signaling in these extra-
hypothalamic regions.  
Future Studies 
To study the role of InsR signals in specific sites of the central nervous 
system (CNS) in regulating the stress axis and anxiety, specific Cre drivers can 
be used to target neurons in various intra-hypothalamic and extra-hypothalamic 
brain regions. For example, Neuromedin S (NMS)-Cre can be used to target 
neurons in the SCN (Kinoshita et al. 2000; Chang 2010). Viral-mediated acute 
knockdown of Insr in intra-hypothalmaic (PVH, SON) and extra-hypothalamic 
(amygdala) regions can be used to study the contribution of InsR signal in each 
of these regions to phenotypes observed in I2.1 KO mice. Acute knockdown would 
also prevent the development compensation for the loss of InsR signal on 
NKX2.1 neurons from birth and may produce a more dramatic phenotype.  
Further studies will also be needed to identify the neuronal AVP that are 
regulated by InsR signals, as well as their downstream targets. In order to 
evaluate the contribution of SON and PVH AVP neurons to the increased 
hypothalamic baseline Avp expression levels, microdissection of each nucleus 
(instead of whole-hypothalamus) can be done to look at gene expression in these 
specific regions. Viral-mediated shRNA knockdown of Avp in either PVH or SON 
in I2.1 KO mice would then allow us to distinguish the contribution of each AVP 
neuronal population to the elevated ME AVP levels. If ME AVP is normalized, we 
could also evaluate the stress response to show the direct involvement of 
elevated baseline AVP in the negative feedback.  
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Hypothalamic AVP has been proposed to increase anxiety-like behaviors 
in rodents. Rat bred for higher anxiety levels have elevated Avp mRNA in the 
PVH (Liebsch et al. 1996; Wigger et al. 2004); while intra-septal injections of 
AVPR1 antagonist reduced anxiety in rats (Liebsch et al. 1996; Toshinai et al. 
2001; Sanchez-Alavez et al. 2010), and activation of AVP receptors in amygdala 
increased anxiety levels (Zhang et al. 2012; Inoue et al. 2013). Together, these 
studies raised that possibility that hypothalamic AVP neurons projecting to the 
septal region and/or amygdala might be involved in the modulation of anxiety 
behaviors. In order to evaluate the effect of increased hypothalamic Avp 
synthesis on the AVP release in the septal regions or amygdala, AVP levels in 
each region can be measured separately by microdissecting out each region 
after the viral-mediated knockdown of Avp in the hypothalamic nucleus. 
Examination of anxiety behaviors in these mice will further confirm a functional 
role of these AVP neurons in mediating the anxiety response in I2.1 KO mice.  
In order to understand the contribution of increased GR signal (due to 
increased CORT release) to the anxiety-like behaviors, ADX I2.1 KO and control 
animals with similar level of glucocorticoid replacement can be subjected to the 
anxiety behavioral tests. If increased CORT contributed to the anxiety 
phenotypes, ADX I2.1 KO would no longer exhibit elevated anxiety levels as 
comparing to the control animals. Furthermore, viral-mediated knockdown of Gr 
in specific brain nuclei in the limbic regions and hypothalamus can then be done 
to identify the CNS regions where GR signaling is mediating this effect.  
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HPA axis dysregulation and anxiety disorders in obesity  
People who are obese have been shown to have an increase risk in 
having affective/mood disorders (including anxiety disorders) and increased HPA 
axis activity (Peeke and Chrousos 1995; Gariepy et al. 2009; Cannon and 
Nedergaard 2011). Results from our studies raise the possibility that decreased 
hypothalamic insulin signal could be involved in the development of HPA axis 
dysfunction and anxiety disorders in diabetes and obesity. Obese humans who 
are leptin-deficient or have mutated leptin receptor gene (with normal glucose 
tolerance) have normal cortisol levels (Montague et al. 1997; Clement et al. 
1998; Kahn and Flier 2000), and obese individual who showed normal glucose 
tolerance also had lower cortisol levels that those who exhibited impaired 
glucose tolerance. Further supporting a role of insulin resistance in the 
development of anxiety disorders in obesity, treating human patients with 
abdominal obesity with insulin sensitizer, thiazolidinedione, for 12 weeks 
significantly reduced both anxiety and depression symptoms, without a significant 
change in body weight (Kemp et al. 2012). Together with our data, these studies 
suggested that reduced hypothalamic insulin signal might be central to the 
development of HPA axis dysregulation and anxiety disorders in obese humans.  
Future Directions 
To understand the contribution of central InsR signal in regulating HPA 
axis functions and anxiety-like behaviors in obese animal models, 
intracerebroventricular (icv) injections of insulin sensitizer e.g. dicohline 
succinate, could be used to increase central insulin signals in obese Lepob/ob 
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mice. We would then evaluate the anxiety scores and HPA axis activity in these 
animals before any changes in body weight or adiposity happen. The advantage 
of using Lepob/ob mice is that the experimental outcomes will not be influenced by 
the effect of insulin on leptin levels. This model can therefore also be used to 
look at the interactions between central InsR and LepR signals in modulating 
anxiety levels by modulating central InsR and LepR signaling levels with icv 
injections of leptin and/or insulin. In combination with viral-mediated knockdown 
of Insr in specific brain regions, the site of action for insulin’s effect can also be 
identified.  
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Conclusions 
In the current study, we have shown that hypothalamic InsR signals have 
a weight- and adiposity- reducing effect in L2.1 KO mice. More importantly, D2.1 
KO mice, but not L2.1 KO mice, also displayed severe dysregulation in HPA axis 
and thermoregulatory response, particularly after overnight fasting in social 
isolation, providing evidence for a critical role of hypothalamic InsR and LepRb 
signals interaction in maintaining normal functions of the HPA and central 
thermoregulatory circuits. The loss of hypothalamic InsR alone led to decreased 
negative feedback in stress response and elevated anxiety-like behaviors, raising 
the possibility that hypersensitivity of HPA axis in obesity may be secondary to 
the underlying central insulin resistance.  
There are some evidence from human studies that support our current 
findings that central insulin suppresses stress response (Bohringer et al. 2008). 
Obese patients with normal glucose tolerance also exhibited lower cortisol levels 
than those who are glucose intolerance. Therefore, it’s possibly that 
hypothalamic insulin resistance is central to the altered response of HPA axis 
seen in obesity (Pasquali and Vicennati 2000; Pasquali et al. 2006). If this is true, 
however, the dramatically enhanced fasting CORT response in D2.1 KO, but not 
I2.1 KO, would suggest that either obesity or reduced hypothalamic LepR signals 
also contribute to development of HPA axis disorders.  
Understanding the contribution of central insulin resistance (sites of action, 
and downstream targets) to the comorbidities in obesity, such as cardiovascular 
diseases, stroke and HPA axis hyperactivity etc., would potentially allow more 
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effective and specific treatments for these disorders by targeting the underlying 
pathways even if weight loss cannot be achieved.  
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Figure 4.1: Fasting body temperature in group-housed D2.1 KO was further 
reduced by single-housing. Fasting core body temperature of group- and 
singly-housed control, L2.1 KO, and D2.1 KO adult males; n ≥ 7 for all groups. All 
data are mean ± SEM. *P < 0.05 for statistical difference between group- versus 
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APPENDIX A: Loss of function study to examine the role of LHX1 in NKX2.1 
neurons in regulating energy balance and the reproductive axis 
Overview  
 The arcuate nucleus of the hypothalamus (ARH) is located in the 
mediobasal hypothalamus, and adjacent to the third ventricle and the median 
eminence, where the blood-brain-barrier is compromised. Therefore, ARH 
neurons are structurally positioned to receive and integrate peripheral metabolic 
signals of energy status to modulate energy metabolism. POMC and AgRP/NPY 
neurons are two of the most studied leptin-sensing neurons in the ARH and have 
been shown to be important for mediating some of leptin’s effect on energy 
balance (Luo et al. 2011; Berglund et al. 2012). Efforts in our lab to identify and 
study the role of non-POMC and non-AgRP/NPY leptin-sensing neurons in the 
ARH were started by a then graduate student - Stephanie Padilla. She performed 
genetic screens and used in situ hybridization to identify molecular markers (non-
POMC and AgRP/NPY) in ARH leptin-sensing neurons.  
Lhx1 is one of the markers that came out from the screen. It encodes 
LIM1 (Lim Homeobox 1), a transcription regulator that is essential for proper 
forebrain development (Shawlot et al. 1999). In the ARH, two functional markers 
are found in LHX1 neurons: Tyrosine hydroxylase (TH), an enzyme that 
catalyzes the synthesis of dopamine; and cocaine- and amphetamine-regulated 
transcript (Cart), which encodes a peptide that signals satiety and increases 
thermogenesis (True et al. 2013) (Figure A1). In order to study the functions of 
the ARH LHX1 neurons, we used mice that have a conditional loss of function of 
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Lhx1 in the hypothalamus using Nkx2.1-Cre (Lhx1Nkx2.1 KO), which is expressed 
in the majority of hypothalamic neurons (Xu et al. 2008). Lhx1Nkx2.1 KO mice were 
confirmed to have ~80% loss of LHX1-positive neurons in the ARH (Figure A2). 
We also detected a non-significant trend of decrease in TH- and Cart-positive 
neurons in the ARH of Lhx1Nkx2.1 KO mice (data not shown). 
Since some ARH LHX1 neurons are LepRb positive, and preliminary study 
showed that Lhx1Nkx2.1 KO females exhibited reduced reproductive capacity 
(smaller litter size), we hypothesized that ARH LHX1 neurons may integrate 
reproductive behaviors and/or functions with metabolic status. We first evaluated 
different metabolic parameters in Lhx1Nkx2.1 KO mice, included baseline and fast-
induced feeding, body weight, body composition, length, glucose levels and 
glucose tolerance, and did not detect any difference (data not shown). High-fat-
diet feeding of Lhx1Nkx2.1 KO from weaning also did not bring out any metabolic 
differences (data not shown). Further study looking at functions of the 
reproductive axis in female Lhx1Nkx2.1 KO mice including the onset of puberty 
(timing of vaginal opening, onset of estrus cycle), estrus cycle properties (length, 
cytology at various stages), gestational length, and latency to mate did not 
identify any changes. We also failed to detect a decrease in litter size found in 
earlier studies (data not shown).  
Dopaminergic neurons in the ARH (part of the tuberinfundibular system) 
project and release dopamine to the median eminence and inhibit prolactin 
secretion from the pituitary (McCann et al. 1984). Prolactin is released in 
response to suckling stimulation during lactation and has been linked to 
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lactational hyperphagia (Woodside 2007), the increase in food intake in lactating 
mothers. Since a subset of ARH LHX1 neurons is TH-positive, we focused our 
study to the lactational period. We did not detect any baseline changes in 
prolactin levels during various stages of the estrus cycle (data not shown). During 
lactation, there was no change in body weight, body composition, food intake and 
glucose levels in Lhx1Nkx2.1 KO females (data not shown). The energy and 
glucose metabolism during lactation did not seem to be altered by the loss of 
ARH Lhx1 expression.  
Since some LHX1 neurons express Esr1 (Estrogen receptor alpha), a final 
study was performed to understand the relationship between hypothalamic LHX1 
neurons and the anorexic effect of estrogen mediated by the hypothalamic 
circuits (Donohoe and Stevens 1982). We ovariectomized female Lhx1Nkx2.1 KO 
mice and replaced estrogen by daily intraperitoneal injection of estradiol for one 
month and the study was continued for another month without estradiol 
injections. Throughout this study (with or without estradiol injections), food intake, 
body weight and adiposity were not different between Lhx1Nkx2.1 KO mice and the 
controls (data not shown).  
Overall, we did not find any metabolic or reproductive phenotypes in 
Lhx1Nkx2.1 KO mice under various experimental conditions, and thus hypothalamic 
LHX1 neurons did not seem to be involved in regulating energy metabolism or 
reproductive functions. Therefore, this project was not pursued further. One 
possible explanation for the lack of phenotypes in Lhx1Nkx2.1 KO mice could be 
due to the compensatory actions of the remaining ARH LHX1-postive neurons to 
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maintain normal functions. A large number of LHX1-postive neurons were 
detected in the region rostral (Suprachiasmatic nucleus anlage) to the primordial 
ARH from E13 to E15 (Figure A4). In adult Lhx1Nkx2.1 KO mice, we detected only 
~20% loss of LHX1-positive neurons in the suprachiasmatic nucleus (SCN) 
(Figure A3), where Nkx2.1 expression is dramatically down-regulated by E13.5 
(Shimogori et al. 2010; Morales-Delgado et al. 2011). Therefore, the transient 
activity of the Nkx2.1-Cre in the SCN anlage might not allow enough time for the 
recombination to occur. This supported the observation that LHX1 neurons in the 
ARH were not completely eliminated in Lhx1Nkx2.1 KO mice and some of these 
neurons might originate from the SCN.  




Figure A1: Functional markers of LHX1-positive neurons in the ARH. LHX1 
colocalized with TH (left) and Cart (middle), but not Pomc-GFP (right) in the 
ARH. LHX1/TH neurons are mainly located in the dorsal ARH; LHX1/Cart 
neurons, dorsal-lateral ARH. (Staining was done by Stephanie Padilla)  
LHX1 TH LHX1 Pomc-GFP LHX1 Cart 




 	  	  	  	  	  	  	  	  	  	  	  	  
 
Figure A2: LHX1 positive neurons in ARH of control (left) and Lhx1Nkx2.1 KO 
(right) adult animals. There was approximately an 80% reduction in LHX1 
positive neurons in the ARH of the Lhx1Nkx2.1 KO adult animals.  





Figure A3: LHX1-positive neurons in the SCN of control (left) and Lhx1Nkx2.1 
KO (right) adult animals. There was about a 20% reduction in LHX1-positive 
neurons in the SCN of Lhx1Nkx2.1 KO adult animals.  




Figure A4: Sagittal sections of primordial ARH showing the distribution of 
LHX1-positive neurons. LHX1-positive neurons are also present in domain 
rostral to the ARH (anlage of the SCN) from E13 to E15. (Staining was done by 
Lori Zeltser)  
E 14 LHX1 Pomc-GFP E 13 LHX1 ISL1 E 15 LHX1 Pomc-GFP  
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